EurekaMag PDF full texts Chapter 30,737

Suzuki, M.; Saito, K.; Nakata, M. 1996: Cosmetic composition and an emulsion composition. Official Gazette of the United States Patent and Trademark Office Patents 1193(5): 3592

Gough, A.D.; De, G., J.M.; Price, J. 1995: Cosmetic composition and process for making it. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1702

Zabotto, A.; Griat, J.; Handjani, R M.; Vanlerberghe, G.G.; Ribier, A.J. 1995: Cosmetic composition based on an aqueous dispersion of small lipid spheres. Official Gazette of the United States Patent and Trademark Office Patents 1177(2): 953-952

Mondet, J.; Ramin, R. 1998: Cosmetic composition comprising a film-forming polymer, preparation, and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1215(1): 495

Mellul, M.; Arnaud, P. 1998: Cosmetic composition comprising a silicone-containing compound and a fatty acid ester. Official Gazette of the United States Patent and Trademark Office Patents 1209(2): 1349

Matsumoto, J.; Uchiyama, Y.; Kambe, T.; Nanba, T.; Okuda, Y. 1997: Cosmetic composition comprising cationic polymer thickener. Official Gazette of the United States Patent and Trademark Office Patents 1195(3): 1864

Gough, A.D.; De, G., J.M.; Price, J. 1996: Cosmetic composition comprising particles of polyisobutylene resin and process for the preparation of same. Official Gazette of the United States Patent and Trademark Office Patents 1193(1): 352

Khoshdel, E.; O'shea, G.J.; Parkington, M.J. 1994: Cosmetic composition comprising sunscreen containing microlatex particles. Official Gazette of the United States Patent and Trademark Office Patents 1169(2): 1071

Vainberg, Y.P.; Kaplina, E.N.; Andosova, I.G. 1996: Cosmetic composition containing a DNA-sodium salt and methods of making and using the same. Official Gazette of the United States Patent and Trademark Office Patents 1189(3): 1993

Samain, H.; Dubief, C.; Cotteret, J. 1997: Cosmetic composition containing a diaminoalkane as an odorless alkalifying agent. Official Gazette of the United States Patent and Trademark Office Patents 1198(2): 1065

Cauwet, D.; Dubief, C. 1997: Cosmetic composition containing a mixture of conditioning polymers. Official Gazette of the United States Patent and Trademark Office Patents 1201(2): 1202

Forestier, S.; Hansenne, I. 1997: Cosmetic composition containing a mixture of metal oxide nanopigments and melanine pigments. Official Gazette of the United States Patent and Trademark Office Patents 1205(2): 1255

Blanc Ferras, E.; Colombie, F.B.; Breda, B.; Courregelogue, J.; Ducase, C.; Moumer, R.; Raymond, P.; Sabadie, M.; Le, G., C.S.; Pol, V.; Pereillo, J.M. 1998: Cosmetic composition containing a neuropeptide Y receptor antagonist. Official Gazette of the United States Patent and Trademark Office Patents 1215(4): 4114

Mougin, N.; Mondet, J.; Guelton, M.; Piot, B.; Dupuis, C.; Cauwet, D. 1998: Cosmetic composition containing a pseudolates having remanence properties. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2492

Nguyen, Q.L.; Colin, C. 1997: Cosmetic composition containing a superoxide dismutase and a porphyrin. Official Gazette of the United States Patent and Trademark Office Patents 1200(4): 2794

Nakajima, T. 1996: Cosmetic composition containing alkenylsuccinic acid ester of saccharide. Official Gazette of the United States Patent and Trademark Office Patents 1193(1): 352

Ozlen, S.N. 1995: Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1704

Sweger, R.W.; Tsai, J.J.; Pasapane, J.; Bernard, K.A. 1996: Cosmetic composition containing amino-multicarboxylate modified starch. Official Gazette of the United States Patent and Trademark Office Patents 1182(2): 1115

Malle, G. 1997: Cosmetic composition containing an N-mercaptoalkylalkanediamide or one of its cosmetically acceptable salts as reducing agent. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 2971-2972

Papantoniou, C.; Mahieu, C. 1989: Cosmetic composition containing an amide amine type condensate and a cosmetic treating process using said condensate us patent 4844889 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 436

Mellul, M.; De, L., P., V. 1997: Cosmetic composition containing an epoxidized oil as plasticizer. Official Gazette of the United States Patent and Trademark Office Patents 1203(2): 1251

Belcour, B.; Martin, R.; Hussler, G. 1997: Cosmetic composition containing as colorant at least one 5-methyoxy-8-methyl-2-phenyl-7H-1-benzopyran-7-one derivative. Official Gazette of the United States Patent and Trademark Office Patents 1204(4): 3061

Cauwet, D.; Dubief, C. 1995: Cosmetic composition containing at least one surface-active agent of the alkyl polyglycoside and/or polyglycerolated type and at least one polyetherurethane. Official Gazette of the United States Patent and Trademark Office Patents 1181(4): 2525

Cauwet, D.; Dubief, C. 1998: Cosmetic composition containing at least one surface-active agent of the alkylpolyglycoside and/or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride/ alkylvinyl ether. Official Gazette of the United States Patent and Trademark Office Patents 1209(4): 3188

Forestier, S.; Moire, C.; Lang, G. 1989: Cosmetic composition containing hydroxylated chalcone derivatives and its use for protecting the skin and the hair against luminous radiations new hydroxylated chalcone derivatives employed and process for their preparation us patent 4867964 september 19 1989. Official Gazette of the United States Patent and Trademark Office Patents 1106(3): 1912

Matsuda, H.; Ito, K.; Taki, A.; Uejima, O. 1995: Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin. Official Gazette of the United States Patent and Trademark Office Patents 1178(1): 335

Hansenne, I.; Forestier, S.; N'guyen, A.L. 1996: Cosmetic composition containing melaninlike pigments in combination with certain tocopherols, and process for protecting the skin, hair, mucosae and cosmetic compositions. Official Gazette of the United States Patent and Trademark Office Patents 1189(3): 1987

Harding, C.R.; Lee, C.M.; Scott, I.R. 1998: Cosmetic composition containing retinol and dioic acid. Official Gazette of the United States Patent and Trademark Office Patents 1206(1): 382

Marchi, P.; Mellul, M. 1997: Cosmetic composition containing solid particles coated with amphoteric polymer. Official Gazette of the United States Patent and Trademark Office Patents 1200(1): 390

Koulbanis, C.; Mellul, M.; Candau, D. 1996: Cosmetic composition containing vinegar as active anti-ageing agent, and its use in the treatment of dermatological ageing. Official Gazette of the United States Patent and Trademark Office Patents 1191(1): 313

Deserable, V.; Bernard, J.C. 1997: Cosmetic composition for composing sticks for the lips or the skin and processes for the preparation thereof. Official Gazette of the United States Patent and Trademark Office Patents 1203(1): 370

Dupuis, C.; Dubief, C. 1997: Cosmetic composition for holding the hairstyle, containing a milk protein and/or milk protein hydrolysate and a keratin hydrolysate. Official Gazette of the United States Patent and Trademark Office Patents 1203(3): 2118

Kealey, G.T.E.; Westgate, G.E.; Williams, R. 1995: Cosmetic composition for inhibiting hair growth. Official Gazette of the United States Patent and Trademark Office Patents 1170(1): 383

Okabe, K. 1997: Cosmetic composition for proliferating indigenous bacteria on skin. Official Gazette of the United States Patent and Trademark Office Patents 1200(4): 2797

Bara, I.; Mellul, M. 1995: Cosmetic composition for the make-up of the skin, containing at least one silicone wax and process for its preparation. Official Gazette of the United States Patent and Trademark Office Patents 1181(4): 2523-2524

Ribier, A.; Simonnet, J T. 1997: Cosmetic composition for the simultaneous treatment of the surface and deep layers of the skin, its use. Official Gazette of the United States Patent and Trademark Office Patents 1196(4): 2597

Grollier J F.; Fourcadier, C. 1989: Cosmetic composition for the treatment of the hair and scalp containing in combination a poly beta alanine and nicotinic acid or an ester thereof us patent 4840790 june 20 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(3): 1774

Jones, M.N.; Kaszuba, M.; Lyle, I.G. 1996: Cosmetic composition for topical application to skin or hair. Official Gazette of the United States Patent and Trademark Office Patents 1185(4): 2652

Lang, G.; Hoch, D.; Konrad, E.; Geibel, W.; Wendel, H.; Kripp, T. 1996: Cosmetic composition for treating skin and hair containing applex wax and methods of making them. Official Gazette of the United States Patent and Trademark Office Patents 1193(4): 2768-2769

Slavtcheff, C.S.; Barrow, S.R.; Kanga, V.D.; Cheney, M.C.; Znaiden, A. 1996: Cosmetic composition for treatment of pimples and redness. Official Gazette of the United States Patent and Trademark Office Patents 1182(2): 1116

Sugawara, T.; Hosokawa, H.; Nakamura, K.; Sawada, M.; Tsutsumi, T. 1997: Cosmetic composition formulated with an aqueous polymer emulsion. Official Gazette of the United States Patent and Trademark Office Patents 1204(3): 2129

Bras Roulier, V.; Mellul, M. 1998: Cosmetic composition in the form of a compact powder and process for preparing it. Official Gazette of the United States Patent and Trademark Office Patents 1214(5): 5245

Nadaud, J.F.; Sebillotte, L. 1996: Cosmetic composition in the form of a gelled triple water/silicone oil/water emulsion. Official Gazette of the United States Patent and Trademark Office Patents 1191(4): 2694

Miguel Colombel, D. 1998: Cosmetic composition in the form of a solid dispersion comprising a fatty phase, a polyhydric alcohol and colorless fillers. Official Gazette of the United States Patent and Trademark Office Patents 1210(2): 1433

Nadaud, J.F.; Sebillotte, L. 1998: Cosmetic composition in the form of a water/oil/water triple emulsion with gelled external phase. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3666

Afriat, I.; Fodor, P.; Pouget, F. 1996: Cosmetic composition in the form of an aqueous gel. Official Gazette of the United States Patent and Trademark Office Patents 1192(2): 1181

Kauffmann, M. 1997: Cosmetic composition in the form of an aqueous gel containing in suspension spheroids of a non-hydrophilic, lipoidal substance. Official Gazette of the United States Patent and Trademark Office Patents 1203(1): 369

Merianos, J.J. 1998: Cosmetic composition of an alpha or beta-hydroxy acid and a polyvinylpyrrolidone complexing agent. Official Gazette of the United States Patent and Trademark Office Patents 1208(3): 2279

Roller, J. 1989: Cosmetic composition particularly for decorative applications us patent 4857306 august 15 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(3): 1787

Green, M.R. 1989: Cosmetic composition us patent 4832946 may 23 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(4): 2559

Ishiwatari, M.; Tsutsumi, Y.; Ogusu, Y.; Kimura, Y. 1989: Cosmetic composition us patent 4857304 august 15 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(3): 1787

Marchi Lemann, P.; Colin, C. 1997: Cosmetic composition which prevents or attenuates the photo-reactivity of titanium dioxide nanopigments. Official Gazette of the United States Patent and Trademark Office Patents 1205(1): 371

Shaku, M.; Ohkura, S.; Kuroda, H.; Kano, A.; Nakabayashi, N. 1995: Cosmetic composition with choline derivative. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1717

Mougin, N.; Mondet, J. 1997: Cosmetic compositions and their uses. Official Gazette of the United States Patent and Trademark Office Patents 1200(1): 365-366

Grollier, J.F.; Dubief, C. 1989: Cosmetic compositions based on cationic polymers and alkyloxazoline polymers us patent 4867966 september 19 1989. Official Gazette of the United States Patent and Trademark Office Patents 1106(3)

Lang, G.; Maresch, G.; Wendel, H.; Konrad, E.; Lenz H R.; Titze, J. 1989: Cosmetic compositions based upon n hydroxypropylchitosans new n hydroxypropylchitosans as well as processes for the production thereof us patent 4835266 may 30 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(5): 3341-3342

Linares, C.G.; Deckner, G.E.; St, J., L.A. 1997: Cosmetic compositions comprising an imidazolium derivative and branched polyethylene glycol. Official Gazette of the United States Patent and Trademark Office Patents 1199(4): 2571

Beucherie, J.; Mercier, J M. 1995: Cosmetic compositions comprising aqueous emulsions of organopolysiloxanes. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1850

Sejpka, J.; Huber, A. 1998: Cosmetic compositions comprising organosiloxanes. Official Gazette of the United States Patent and Trademark Office Patents 1209(2): 1353-1354

Traitler, H.; Viret, J L. 1995: Cosmetic compositions containing 2,3-butanediol fatty acid diesters. Official Gazette of the United States Patent and Trademark Office Patents 1181(2): 1118

Grollier, J.F.; Dubief, C.; Mondet, J. 1989: Cosmetic compositions containing a cationic polymer and an anionic polymer as thickening agent us patent 4839166 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1201

Cauwet Martin, D.; Dubief, C. 1998: Cosmetic compositions containing a lipid ceramide compound and a peptide having a fatty chain, and their uses. Official Gazette of the United States Patent and Trademark Office Patents 1216(1): 485-486

Kim, Y.D.; Kim, C.K.; Lee, C.N.; Ha, B.J. 1995: Cosmetic compositions containing a polyethoxylated vitamin E. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1701

Cauwet Martin, D.; Dubief, C. 1997: Cosmetic compositions containing a synergistic mixture of conditioning polymers. Official Gazette of the United States Patent and Trademark Office Patents 1196(3): 1840-1841

Mellul, M.; De, L., P., V. 1996: Cosmetic compositions containing an expoxidized oil as plasticizer. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2798

Cauwet, D.; Dubief, C. 1998: Cosmetic compositions containing at least one anionic surfactant of alkylgalactoside uronate type and at least one nonionic surfactant of alkylpolyglycoside and/or polyglycerolated type. Official Gazette of the United States Patent and Trademark Office Patents 1210(4): 3491-3492

Cauwet, D.; Dubief, C. 1998: Cosmetic compositions containing at least one anionic surfactant of alkylgalactoside uronate type and at least one synthetic hydrocarbon oil. Official Gazette of the United States Patent and Trademark Office Patents 1217(5): 4061

Cho, S.H.; Gottlieb, K.; Santhanam, U. 1996: Cosmetic compositions containing betulinic acid. Official Gazette of the United States Patent and Trademark Office Patents 1187(4): 2770

Bracco, U. 1995: Cosmetic compositions containing fatty acid triglyceride mixtures. Official Gazette of the United States Patent and Trademark Office Patents 1177(5): 3192

Bollens, E.; Mahieu, C. 1998: Cosmetic compositions containing hydrofluorocarbon compounds. Official Gazette of the United States Patent and Trademark Office Patents 1206(1): 386

Billmers, R.L.; Solarek, D.B.; Tolcinsky, M.; Ronco, D.L.; Pasapane, J. 1998: Cosmetic compositions containing hydrophobic starch derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1212(1): 519

Coffindaffer, T.W.; Monich, M.S.; Leitch, S.H.; Bolich, R.E.Jr; Mccall, R.E. 1998: Cosmetic compositions containing hydrophobically modified nonionic polymer and unsaturated quaternary ammonium surfactant. Official Gazette of the United States Patent and Trademark Office Patents 1217(1): 405-406

Mitchnick, M.; O'lenick, A.J.Jr 1996: Cosmetic compositions containing hydrophobized zinc oxide. Official Gazette of the United States Patent and Trademark Office Patents 1188(3): 2013

Lang, G.; Malaval, A.; Leduc, M. 1989: Cosmetic compositions containing hydroxyl derivatives of dibenzoylmethane and their use in protecting the skin against uv rays and derivatives for use therein us patent 4814162 march 21 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(3): 1656

Bartolone, J.B.; Penska, C.M.; Santhanam, U.; Lang, B.D. 1997: Cosmetic compositions containing lactate dehydrogenase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1204(4): 3001

Lamothe, J P.H.G.; Marchenay, Y.G.; Monsan, P.F.; Paul, F.M.B.; Pelenc, V. 1996: Cosmetic compositions containing oligosaccharides. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 1940

Pillai, S.; Gottlieb, K.A.; Brinker, A.M.; Mahajan, M.; Rawlings, A.V. 1998: Cosmetic compositions containing phytovitamin D. Official Gazette of the United States Patent and Trademark Office Patents 1212(1): 517

Login, R.B.; Chaudhuri, R.K.; Tracy, D.J.; Helioff, M.W. 1989: Cosmetic compositions containing quaternized nitrogen containing compound us patent 4834970 may 30 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(5): 3266

Deluca, H.F.; Smith, C.M. 1994: Cosmetic compositions containing secosterol compounds. Official Gazette of the United States Patent and Trademark Office Patents 1168(4): 2503

Pillai, S.; Mahajan, M.N.; Rawlings, A.V. 1996: Cosmetic compositions containing tricholine citrate. Official Gazette of the United States Patent and Trademark Office Patents 1192(1): 366

Langlois, A. 1998: Cosmetic compositions containing water dispersible pigment which is surface treated with a polymer and process. Official Gazette of the United States Patent and Trademark Office Patents 1217(5): 4062

Mellul, M.; De, L., P., V. 1997: Cosmetic compositions for application to the nail. Official Gazette of the United States Patent and Trademark Office Patents 1195(2): 1116

Tricaud, C.; Millequant, J M.; Sebag, H. 1997: Cosmetic compositions for bleaching the hair, preparation, process and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1201(4): 2659

Snyder, F.; Reinhart, G.; Digirolamo, D. 1995: Cosmetic compositions for lengthening, coloring and curling eyelashes. Official Gazette of the United States Patent and Trademark Office Patents 1171(2): 1005

Dupuis, C. 1997: Cosmetic compositions for maintaining hairstyle possessing improved fixing power. Official Gazette of the United States Patent and Trademark Office Patents 1197(3): 1813

Burdzy, E. 1996: Cosmetic compositions for non-white pigmented skin. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 1938

Znaiden, A.P.; Cheney, M.C.; Slavtcheff, C.S.; Cho, S.H. 1996: Cosmetic compositions for reducing or preventing signs of cellulite. Official Gazette of the United States Patent and Trademark Office Patents 1188(3): 2014

Mahieu, C.; Papantoniou, C. 1995: Cosmetic compositions for the treatment of the hair and skin contain polymer constituted essentially by repeating units of the beta-alanine type. Official Gazette of the United States Patent and Trademark Office Patents 1171(2): 1004-1005

Znaiden, A.P.; Crotty, B.A.; Johnson, A.W. 1997: Cosmetic compositions for treating itchy skin. Official Gazette of the United States Patent and Trademark Office Patents 1196(4): 2677-2678

Wolf, B.A.; Snyder, F. 1995: Cosmetic compositions having keratolytic and anti-acne activity. Official Gazette of the United States Patent and Trademark Office Patents 1178(2): 942

Keri, T.; Kristof, J. 1989: Cosmetic compositions having skin calming and skin regenerating effect and process for the preparation thereof us patent 4855137 august 8 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(2): 1039

Kanga, V.; Znaiden, A.P. 1997: Cosmetic compositions including polyisobutene. Official Gazette of the United States Patent and Trademark Office Patents 1205(2): 1260

Ensley, B.D.; Ludmer, M. 1998: Cosmetic compositions including tropoelastin isomorphs. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1383

Berthiaume, M.D. 1997: Cosmetic compositions made with hydroxy carbamate functionalized silicones. Official Gazette of the United States Patent and Trademark Office Patents 1202(5): 3802

Lang, G.; Maresch, G.; Lenz H R.; Konrad, E.; Breuer, L.; Hoch, D. 1989: Cosmetic compositions on the basis of alkylhydroxypropyl substituted chitosan derivatives new chitosan derivatives and processes for the production thereof us patent 4845204 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 523

Hartmann, P.; Koehler, J. 1989: Cosmetic compositions with a content of hydrogen peroxide and alpha bisabolol as well as use of alpha bisabolol for the stabilization of hydrogen peroxide us patent 4844886 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 435

Castrogiovanni, A.; Barone, S.J.; Krog, A.; Mcculley, M.L.; Callelo, J.F. 1996: Cosmetic compositions with improved transfer resistance. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1120

Miranda, F.; Brandao, F.; Silva, R. 1990: Cosmetic contact dermatitis 1984 1989. Contact Dermatitis 23(4): 242

Green, H.; Dijan, P. 1996: Cosmetic containing comeocyte proteins and transglutaminase, and method of application. Official Gazette of the United States Patent and Trademark Office Patents 1187(2): 1164

Shaila, S.; Ashwini, T. 1991: Cosmetic cystolithotomy. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 286

Hayward, J.A.; Goldstein, M.S.; Brown, M.; Ceccoli, J.D. 1996: Cosmetic delivery system for salicyclic acid and process for preparation of same. Official Gazette of the United States Patent and Trademark Office Patents 1193(3): 2015

Berndt, D. 1997: Cosmetic delivery vehicles and related compositions. Official Gazette of the United States Patent and Trademark Office Patents 1198(1): 333-334

Lacy, A. 1991: Cosmetic dentistry clinical techniques and applications of dental materials research. Journal of Dental Research 70(Special Issue): 356

Murphy, R.T. 1996: Cosmetic deodorant compositions containing encapsulated bicarbonate and liquid fragrance ingredients. Official Gazette of the United States Patent and Trademark Office Patents 1193(3): 2011

Dillenburg, H.; Jakobson, G.; Klein, W.; Siemanowski, W.; Uhlig, K.; Wolf, F. 1997: Cosmetic deodorant preparation containing di- or triglycerin esters. Official Gazette of the United States Patent and Trademark Office Patents 1200(3): 2029

Murphy, R.T.; Bergmann, W.R. 1997: Cosmetic deodorant products containing a polymer/fragrance-encapsulated bicarbonate ingredient. Official Gazette of the United States Patent and Trademark Office Patents 1196(4): 2590

Bergmann, W.R.; Murphy, R.T. 1997: Cosmetic deodorant products containing encapsulated co-micronized bicarbonate ingredient. Official Gazette of the United States Patent and Trademark Office Patents 1198(3): 1782

Wedgwood, D. 1992: Cosmetic extensile exposure of the facial skeleton. British Journal of Oral and Maxillofacial Surgery 30(5): 323-325

Piot, B.; Mellul, M. 1998: Cosmetic eye makeup composition comprising a wax microdispersion. Official Gazette of the United States Patent and Trademark Office Patents 1217(3): 2467

Dobbs, S.W. 1995: Cosmetic film forming compositions which are freeze-thaw stable. Official Gazette of the United States Patent and Trademark Office Patents 1170(2): 1137

Moy, L.S. 1998: Cosmetic formulation and method for amelioration of skin keratoses and striae distensae. Official Gazette of the United States Patent and Trademark Office Patents 1211(1): 403

Tsubaki, S.; Noda, I. 1995: Cosmetic formulations. Official Gazette of the United States Patent and Trademark Office Patents 1181(1): 352-353

Chang, M.-J.; Huang, H.-C.; Chang, H.-C.; Chang, T.-M. 2008: Cosmetic formulations containing Lithospermum erythrorhizon root extract show moisturizing effects on human skin. Archives of Dermatological Research 300(6): 317-323

Franz, K.D.; Griessman, A.; Lenz, G.; Gerau, G.; Moeschl, G. 1989: Cosmetic formulations with carrier free iron oxide platelets us patent 4828826 may 9 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(2): 1147

Hilliard, P.R.Jr; Moghe, B.D.; Ross, L. 1998: Cosmetic gel composition having reduced skin irritation. Official Gazette of the United States Patent and Trademark Office Patents 1208(4): 3206

Brazinsky, J.; Shin, C.T.; Alonso, R.; Benfatto, A. 1994: Cosmetic gel stick compositions. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3259

Dupuis, C. 1998: Cosmetic hair care foam composition. Official Gazette of the United States Patent and Trademark Office Patents 1216(1): 475

Golz, K.; Zastrow, L.; Stanzl, K.; Braunagel, A. 1998: Cosmetic kaolin-containing preparation. Official Gazette of the United States Patent and Trademark Office Patents 1207(2): 1252

Thibault, P.; Bray, A.; Wlodarczyk, J.; Lewis, W. 1990: Cosmetic leg veins: evaluation using duplex venous imaging. Journal of Dermatologic Surgery and Oncology 16(7): 612-618

Arraudeau J P.; Patraud J.; Le Gall L. 1989: Cosmetic make up composition us patent 4820510 april 11 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(2): 1158-1159

Mellul, M. 1997: Cosmetic make-up composition containing a fullerene or mixture of fullerenes as a pigmenting agent. Official Gazette of the United States Patent and Trademark Office Patents 1196(3): 1840

Defossez, B.; Rossignol, S. 1996: Cosmetic make-up composition containing a transparent titanium oxide and silicon oxide pigment. Official Gazette of the United States Patent and Trademark Office Patents 1182(4): 2474

Slavtcheff, C.S. 1998: Cosmetic mask. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 381-382

Couldwell, W.T.; Fukushima, T. 1993: Cosmetic mastoidectomy for the combined supra/infratentorial transtemporal approach. Technical note. Journal of Neurosurgery 79(3): 460-461

Pawelek, J.M.; Platt, J.T. 1998: Cosmetic melanins. Official Gazette of the United States Patent and Trademark Office Patents 1209(4): 3184

Meyers, A.J.; Evenson, A.; Dorogi, P.; Mccook, J.P. 1995: Cosmetic method for treatment of skin. Official Gazette of the United States Patent and Trademark Office Patents 1172(4): 2487

Cancro, L.P. 1990: Cosmetic mouthwashes. Waggoner, W C (Ed ) Cosmetic Science And Technology Series, Vol 8 Clinical Safety And Efficacy Testing Of Cosmetics Xvii+332p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 271-284

Crawford, R. 1996: Cosmetic nanosurgery. Crandall, B C Nanotechnology: Molecular speculations on global abundance 61-80

N'guyen, Q.L. 1996: Cosmetic of dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol. Official Gazette of the United States Patent and Trademark Office Patents 1193(4): 2767-2768

Ribier, A.; Simonnet, J T.; Griat, J. 1997: Cosmetic or dermatological composition comprising an oil-in-water emulsion based on oily globules provided with a lamellar liquid crystal coating. Official Gazette of the United States Patent and Trademark Office Patents 1201(3): 2043-2044

Candau, D.; Khayat, C.; Agnus Ancilotti, D. 1998: Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin. Official Gazette of the United States Patent and Trademark Office Patents 1212(1): 520

Meybeck, A.; Bonte, F.; Dumas, M. 1997: Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 431

Ribier, A.; Biatry, B. 1998: Cosmetic or dermatological composition in the form of an aqueous and stable dispersion of cubic gel particles based on phytanetriol and containing a surface-active agent which has a fatty chain, as dispersing and stabilizing agent. Official Gazette of the United States Patent and Trademark Office Patents 1216(2): 1711

Soudant, E.; Koulbanis, C. 1998: Cosmetic or dermatological composition with controlled release of active principle containing a photoconvertible carotenoid. Official Gazette of the United States Patent and Trademark Office Patents 1206(4): 2977

Spagnoli, R.; Varkados, M. 1997: Cosmetic or dermatological compositions containing ribosomes. Official Gazette of the United States Patent and Trademark Office Patents 1201(1): 362

Masson, G.; Candau, D.; Khayat, C. 1997: Cosmetic or dermatological powder, its preparation process and its uses. Official Gazette of the United States Patent and Trademark Office Patents 1196(1): 322

Uhlmann, B.; Mann, T.; Gers Barlag, H.; Sauermann, G. 1996: Cosmetic or dermatological preparation comprising delta-aminolevulinic acid content as an active ingredient. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2728

Gers Barlag, H.; Schulz, S.; Uhlmann, B.; Hintze, U.; Schmucker, R. 1997: Cosmetic or dermatological preparations comprising hydrophobicized inorganic pigments for preserving the urocaninic acid state of the skin. Official Gazette of the United States Patent and Trademark Office Patents 1201(3): 2040

N'guyen, Q.L. 1995: Cosmetic or dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol. Official Gazette of the United States Patent and Trademark Office Patents 1176(2): 1083

Bara, I.; Mellul, M. 1997: Cosmetic or dermopharmaceutical compositions in the form of aqueous gels modified by the addition of expanded microspheres. Official Gazette of the United States Patent and Trademark Office Patents 1194(2): 1145

Rodriguez, S.N. 1989: Cosmetic or drug the minotaurs labyrinth revisited. Food Drug Cosmetic Law Journal 44(1): 63-86

Weuffen, W.; Kramer, A.; Tirsch, C.; Meffert, H.; Koch, S.; Sima, D. 1997: Cosmetic or pharmaceutic preparations for improving hair quality and stimulating growth of the hair. Official Gazette of the United States Patent and Trademark Office Patents 1198(2): 1066-1067

Andre, P.; Darnault, S.; Renimel, I. 1998: Cosmetic or pharmaceutical and particularly dermatological, composition containing an extract of tephrosia, particularly Tephrosia purpurea. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2111

Philippe, M.; Semeria, D.; Bollens, E. 1996: Cosmetic or pharmaceutical composition comprising an alkyl carbamate as hydrating agent. Official Gazette of the United States Patent and Trademark Office Patents 1193(4): 2767

Lion, B.; Mondet, J.; Cazeneuve, C. 1997: Cosmetic or pharmaceutical composition comprising an aqueous dispersion of polymer. Official Gazette of the United States Patent and Trademark Office Patents 1200(4): 2799

Bonte, F.; Meybeck, A.; Dumas, M. 1996: Cosmetic or pharmaceutical composition containing a black horehound extract. Official Gazette of the United States Patent and Trademark Office Patents 1186(1): 352

N'guyen, Q L. 1997: Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract. Official Gazette of the United States Patent and Trademark Office Patents 1204(2): 1252-1253

Bonte, F.; Meybeck, A.; Dumas, M. 1997: Cosmetic or pharmaceutical composition containing a prunella extract. Official Gazette of the United States Patent and Trademark Office Patents 1197(5): 3198

Meybeck, A.; Bonte, F.; Dumas, M. 1996: Cosmetic or pharmaceutical composition containing an extract of Coleus esquirolii, Coleus scutellarioides or Coleus xanthanthus. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1119

Meybeck, A.; Bonte, F.; Dumas, M. 1997: Cosmetic or pharmaceutical composition containing an extract of coleus esquirollii, coleus scutellarioides or coleus xanthanthus. Official Gazette of the United States Patent and Trademark Office Patents 1200(3): 2028

Grollier, J F.; Hansenne Richoux, I. 1997: Cosmetic or pharmaceutical composition for the treatment of hair and of the scalp. Official Gazette of the United States Patent and Trademark Office Patents 1196(2): 1173

Voultoury, R.; Scott, A M. 1997: Cosmetic or pharmaceutical composition for topical use. Official Gazette of the United States Patent and Trademark Office Patents 1200(1): 366

Nadaud, J F. 1997: Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusion therein. Official Gazette of the United States Patent and Trademark Office Patents 1199(1): 335

Bonte, F.; Meybeck, A. 1997: Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss. Official Gazette of the United States Patent and Trademark Office Patents 1196(1): 328

Meybeck, A.; Bonte, F.; Dumas, M. 1995: Cosmetic or pharmaceutical composition, especially dermatological composition, intended for promoting the pigmentation of the skin or hair, containing an extract of cyperus, and the process for its manufacture. Official Gazette of the United States Patent and Trademark Office Patents 1181(3): 1816

Rouillard, F.; Josse, A.; Robin, J R. 1998: Cosmetic or pharmaceutical compositions containing, as active ingredient, mangiferine or its derivatives, in pure form or in plant extracts. Official Gazette of the United States Patent and Trademark Office Patents 1215(3): 2929

Gruning, B.; Weitemeyer, C. 1997: Cosmetic or pharmaceutical preparations. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1202

Chiou, R.K. 1990: Cosmetic orchiectomy for prostate cancer. Urologic Clinics of North America 17(1): 13-16

Catton P.; Taylor G.; Mackenzie R.; Ackerman I.; Et Al 1991: Cosmetic outcome of surgery in patients treated with partial mastectomy and radiation for stage 1 and 2 breast. Clinical and Investigative Medicine 14(4 Suppl): A109

Powers, R.J. 1995: Cosmetic pencil. Official Gazette of the United States Patent and Trademark Office Patents 1173(3): 1786

Powers, R.J. 1994: Cosmetic pencil with descending sheath. Official Gazette of the United States Patent and Trademark Office Patents 1168(4): 2370-2371

Khamis, A.A. 1995: Cosmetic pigment coating and method of application in nail polish. Official Gazette of the United States Patent and Trademark Office Patents 1180(4): 2479

Lafleur, P.A.; Vadaketh, L.; Leppla, J.K. 1997: Cosmetic powder compositions having improved skin coverage. Official Gazette of the United States Patent and Trademark Office Patents 1201(3): 2044

Macchio, R.A.; Brown, I.; Tietjen, M. 1989: Cosmetic powder employing spherical silica particles us patent 4837011 june 6 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(1): 429-430

Murphy, J.H.; Curtis, E.S.; Horton, D.D. 1989: Cosmetic powder product us patent 4820518 april 11 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(2): 1160

Fukasawa, J.; Kato, H.; Iwaya, K.; Shimizu, T.; Kawano, A. 1989: Cosmetic powders us patent 4857308 august 15 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(3): 1788

Shanni, D. 1997: Cosmetic preparations for moisturizing human skin containing specific lipids. Official Gazette of the United States Patent and Trademark Office Patents 1198(3): 1782

Eustatiu, L. 1996: Cosmetic preparations for revitalizing the skin. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2749

Giede, K.; Seidel, K.; Mueller, R.; Hollenberg, D. 1997: Cosmetic preparations for the hair. Official Gazette of the United States Patent and Trademark Office Patents 1196(3): 1840

Baraldi, P.G.; Guarneri, M.; Bader, S.; Zanotti, F.; Manfredini, S.; Spalluto, G.; Cacciari, B.; Brigidi, P. 1995: Cosmetic preservation and structure-activity relationships of 4-diazo-pyrazole-5-carboxamides. International Journal of Cosmetic Science 17(4): 147-156

Rocher, D.; Noel, H. 1996: Cosmetic product having a stabilized redox potential. Official Gazette of the United States Patent and Trademark Office Patents 1189(3): 1991

Murphy, L.J. 1997: Cosmetic product including water soluble fiber. Official Gazette of the United States Patent and Trademark Office Patents 1201(1): 359

Shimono, F.; Yamamoto, K.; Onishi, T.; Miyoshi, R. 1998: Cosmetic products containing a soluble glass. Official Gazette of the United States Patent and Trademark Office Patents 1211(3): 2793

Bel Prieto, E.; Sune Arbussa, J.M. 1996: Cosmetic products law today. Ciencia Pharmaceutica 6(3): 163-167

Bowser, P.A.; Sturmey, I.C. 1989: Cosmetic products us patent 4839161 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1200

Janssens, J.; Struyven, M.; Bonte, J. 1989: Cosmetic results after conservative surgery and radiotherapy in breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 30: 255

Abner, A.; Recht, A.; Vicini, F.; Silver, B.; Harris, J.R. 1990: Cosmetic results after conservative surgery chemotherapy ctx and radiation therapy rt for early breast carcinoma. International Journal of Radiation Oncology, Biology, Physics 19(Suppl 1): 174

Krishnan, L.; Jewell, W.R.; Mansfield, C.M.; Reddy, E.K.; Thomas, J.H.; Krishnan, E.C. 1992: Cosmetic results in early stage breast cancer treated with a peri-operative boost irradiation. Breast Cancer Research and Treatment 23(1-2): 163

Perlman, P.W.; Nathan, M.J. 1991: Cosmetic rhinoplasty using the external approach. Ear Nose and Throat Journal 70(7): 425-430

Suzuki, M. 1990: Cosmetic safety skin reaction due to cosmetic ingredients. Hifu 32(Suppl 9): 1-12

Moir, D.; O'connell R.M. 1989: Cosmetic sampler us patent 4848378 july 18 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(3): 1662

Grollier, J.F. 1989: Cosmetic screening composition containing a uv screen in combination with a polymer obtained by block polymerization in emulsion and its use for the protection of the human epidermis against uv radiations us patent 4804531 february 14 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(2): 804

Guerrero, A.A.; Corey, J.M. 1998: Cosmetic skin conditioning compositions containing a salicyloxy alpha-carboxy acid. Official Gazette of the United States Patent and Trademark Office Patents 121(2): 1576

Hirose, O.; Arima, Y.; Kawaguchi, K.; Ogino, Y.; Suzuki, M.; Matsunaga, K.; Hayakawa, R. 1989: Cosmetic skin disorders in 1987. Hifu 31(Suppl 7): 81-86

Ogino, Y.; Arisu, K.; Suzuki, M.; Matsunaga, K.; Hirose, O.; Arima, Y.; Hayakawa, R. 1990: Cosmetic skin disorders in 1988. Hifu 32(Suppl 9): 106-114

Penska, C.; Santhanam, U.; Habif, S. 1998: Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide. Official Gazette of the United States Patent and Trademark Office Patents 1217(4): 3282-3283

Bui Bertrand, L.; Louvet Plaisant, N. 1997: Cosmetic skin-cleansing mask compositions containing graded spheroidal polyamide particles. Official Gazette of the United States Patent and Trademark Office Patents 1204(4): 3002

Herstein, M. 1997: Cosmetic skin-renewal-stimulating composition with long-term irritation control. Official Gazette of the United States Patent and Trademark Office Patents 1197(1): 313

Cashin, C.J.; Hubner, F.N. 1998: Cosmetic stick compositions containing di-and triblock copolymers. Official Gazette of the United States Patent and Trademark Office Patents 1210(4): 3492

Schneider, G.; Klier, M.; Aul, M.; Teichmann, S. 1995: Cosmetic sticks. Official Gazette of the United States Patent and Trademark Office Patents 1180(2): 977

Sabatelli, A.D. 1989: Cosmetic sticks us patent 4822602 april 18 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(3): 1887-1888

Finkel, P.; Voss, E. 1994: Cosmetic sunscreen. Official Gazette of the United States Patent and Trademark Office Patents 1169(2): 1071

Tur, W. 1989: Cosmetic sunscreen product for the face and body us patent 4844884 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 434-435

Hems, T.E.; Godfrey, A. 1990: Cosmetic surgery for Cornelia de Lange syndrome. British Journal of Plastic Surgery 43(4): 489-491

Van der Velden, E.M.; de Jong, B.D.; van der Walle, H.B.; Stolz, E.; Naafs, B. 1993: Cosmetic tattooing as a treatment of port-wine stains. International Journal of Dermatology 32(5): 372-375

Gough, A.D.; Khoshdel, E.; Polywka, R. 1996: Cosmetic treatment of substrates. Official Gazette of the United States Patent and Trademark Office Patents 1187(2): 1163

Komori, T.; Asahi, M.; Suzuki, T. 1989: Cosmetic us patent 4839162 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1200

Forestier, S.; Lang, G.; Richard, H. 1995: Cosmetic use of benzalmalonate diorganopolysiloxanes and novel cosmetic compositions containing such compounds for the protection of skin and hair. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1848

VinodKamath; Mohile,R.B.; AartiRele 2008: Cosmetic use of coconut oil. Indian Coconut Journal: 2, 7-9

Salini, A. 1997: Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use. Official Gazette of the United States Patent and Trademark Office Patents 1199(2): 1078

Itin, P.H.; Schiller, P.; Mathys, D.; Guggenheim, R. 1997: Cosmetically induced hair beads. Journal of the American Academy of Dermatology 36(2 Part 1): 260-261

Cerezo Galan, A. 1995: Cosmetics Innocuousness and efficacy. Ciencia Pharmaceutica 5(3): 127-131

Miyanji, M.J. 1991: Cosmetics and their adverse effects. East African Medical Journal 68(6): 401-403

Segerstrom, E.J. 1996: Cosmetics and their selection, application, and distribution. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2497-2498

Honda, S.; Akerkoshi, Y.; Arai, Y. 1995: Cosmetics based on naturally derived melanin-coated pigments. Official Gazette of the United States Patent and Trademark Office Patents 1170(2): 1090

Neher, J.O. 1989: Cosmetics by prescription. Journal of Family Practice 29(5): 534-536

Cauwet, D.; Dubief, C. 1998: Cosmetics compositions containing at least one anionic suracant of alkylgalactoside uronate type and at least one amphoteric polymer. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 379-380

Picken, H.M.Jr 1998: Cosmetics containing citrus water distillate. Official Gazette of the United States Patent and Trademark Office Patents 1209(3): 2275

Rouse, W.; Valles, M.; Martino, G.T.; Chiu, C W. 1996: Cosmetics containing enzymatically debranched starch. Official Gazette of the United States Patent and Trademark Office Patents 1184(1): 420

Nagai, M.; Kawada, H.; Tsuchiya, M.; Yamasaki, S.; Yamamuro, A.; Ono, T. 1998: Cosmetics containing guanidine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1208(1): 361

Horino, M.; Hasegawa, Y. 1998: Cosmetics containing silicone surface-modified particles of titanium oxide and zinc oxide. Official Gazette of the United States Patent and Trademark Office Patents 1209(4): 3184

Brauer, E.W. 1990: Cosmetics for the dermatologists. Sauer, G C Manual Of Skin Diseases, Sixth Edition Xxii+419p J B Lippincott Co : Philadelphia, Pennsylvania, Usa; London, England, Uk Illus Maps 62-68

Yoshioka, T.; Masuda, H.; Tanaka, H. 1996: Cosmetics having sunscreen properties. Official Gazette of the United States Patent and Trademark Office Patents 1193(3): 2011

Ibe, S. 1989: Cosmetics us patent 4818751 april 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(1): 526

Krzysik, D.G. 1995: Cosmetics with enhanced durability. Official Gazette of the United States Patent and Trademark Office Patents 1178(3): 1694-1695

Morganti, P. 1990: Cosmetologic impact. Adashi, E Y And S Mancuso (Ed ) Serono Symposia Publications From Raven Press, Vol 73 Major Advances in Human Female Reproduction; Rome, Italy, May 10-12, Xvi+410p Raven Press: New York, New York, Usa Illus 369-370

Sparavigna, A.; Galbiati, G. 1991: Cosmetological dermatology science of the interaction between skin and cosmetics. Chronica Dermatologica 1(2): 175-186

Klochek, N.V.; Palamarchuk, L.E.; Plyusnina, L.A.; Nikonova, M.V. 1993: Cosmic action of unknown nature. Biophysics (English Translation of Biofizika) 37(4): 555-559, 1992

Harkaly, A. 1990: Cosmic and environmental influences on plants testing of sowing calendar on beans phaseolus vulgaris in brazil research done in this area until today and its future implications in agriculture. Tomassen, G J M , Et Al (Ed ) Geo-Cosmic Relations; The Earth And Its Macro-Environment; First International Congress, Amsterdam, Netherlands, April 19-22, 1989 Xi+364p Pudoc: Wageningen, Netherlands Illus 356-357

Delsemme, A.H. 1998: Cosmic origin of the biosphere. Brack, A The molecular origins of life: Assembling pieces of the puzzle 100-118

Nicholas, J.; Lackland, D.; Hoel, D.; Dunbar, J.; MohrL.Jr.; Kaune, W. 1997: Cosmic radiation and electromagnetic fields Exposure among aircrew. American Journal of Epidemiology 145(11 Suppl): S50

Wilson, O.J.; Young, B.F.; Richardson, C.K. 1994: Cosmic radiation doses received by Australian commercial flight crews and the implications of ICRP 60. Health Physics 66(5): 493-502

Nagaoka, K.; Honda, K.; Miyano, K. 1997: Cosmic ray contribution in the measurement of environmental gamma ray dose. Wei, L, Sugahara, T, Tao, Z International Congress Series; High levels of natural radiation, 1996 Radiation dose and health effects 25-30

Begemann, F.; Vilcsek, E.; Rieder, R.; Born, W.; Waenke, H. 1970: Cosmic-ray produced radioisotopes in lunar samples from the Sea of Tranquillity Apollo 11. Pages 995-1005 1970

Lopez Garcia, V. 1992: Cosmical vision of biological aging. Geriatrika 8(9): 17-22

Parrish, J.E.; Eichler, E.E.; Schofield, T.; Chinault, A.C.; Graves, M.; Arenson, A.; Lee, C.C.; Nelson, D.L. 1995: Cosmid binning and cDNA identification in human Xq28. American Journal of Human Genetics 57(4 Suppl): A267

Jaeger, C.; Hiendleder, S. 1994: Cosmid cloning and characterization of the coding regions and regulatory elements of the ovine-alpha- , beta-A- and beta-b-inhibin genes. Animal Genetics 25(Suppl 2): 33

Yu, C.Y.; Wu, L.C.; Buluwela, L.; Milstein, C. 1993: Cosmid cloning and walking to map human CD1 leukocyte differentiation antigen genes. Methods in Enzymology 217: 378-398

Nishio, T.; Kusaba, M.; Suto, E.G.; Sakamoto, K.; Okazaki, K.; Kayano, T. 1996: Cosmid cloning of S-locus from B oleracea. Plant Physiology (Rockville) 111(2 Suppl): 149

Meier, T.I.; Dick, J.W. 1989: Cosmid cloning of pasteurella multocida dna in escherichia coli dh1 and expression of a pasteurella multocida specific antigen. Poultry Science 68(Suppl 1): 94

Lanning, D.; Lafuse, W.P. 1994: Cosmid cloning of the H-2S/D region of the mouse major histocompatibility complex. FASEB Journal 8(4-5): A517

Walter, L.; Günther, E. 1995: Cosmid cloning of the RT1.A encompassing region of the rat major histocompatibility complex. Transplantation Proceedings 27(2): 1501

Dickinson, D.P.; Dempsey, L.D.; Millar, S.J. 1990: Cosmid cloning of the human type 2 cystatin gene family. Journal of Dental Research 69(Special Issue): 167

Wenzel, R.; Hermann, R. 1996: Cosmid cloning with small genomes. Birren, B Author, Lai, E Author Nonmammalian genomic analysis: A practical guide 197-222

Ivens, A.C.; Strivens, M.A.; Heding, I.J.; John, R.M.; Porteous, D.J.; Van Heyningen, V.; Mannens, M.; Hoovers, J.M.; Little, P.F. 1991: Cosmid contig analysis of human chromosome region 11p identification of zinc finger motif clusters. Cytogenetics and Cell Genetics 58(1-4): 1964

Osstra, B.A.; Verkerk, A.J.; Eussen, B.E.; Bakker, C.E.; Van Der Helm, R.M.; Niermeijer, M.F.; Van Ommen G J.B.; Van Oost, B.A.; Nelson, D.L.; Warren, S.T. 1991: Cosmid contig around the fragile site fraxa. Cytogenetics and Cell Genetics 58(1-4): 2079

Vidal, J.M.; Bergonon, S.; Lopez Acedo, C.; Oliva, R. 1996: Cosmid contig construction in the chromosome 21 ETS2-HMG14 region. European Journal of Human Genetics 4(Suppl 1): 21

Frischauf, A.M.; Obermayr, F.; Chadwick, B.; Morris, D.; Mott, R.; Williamson, J.; Sheer, D.; Lehrach, H.; Reis, A. 1995: Cosmid contigs and transcripts in the region of the Gorlin syndrome gene. American Journal of Human Genetics 57(4 Suppl): A64

Hawkins, G.A.; Bishop, M.D.; Toldo, S.S.; Kappes, S.M.; Ponce, D.L., F.A.; Fries, R.; Beattie, C.W. 1994: Cosmid directed linkage mapping of the bovine genome. Journal of Dairy Science 77(Suppl 1): 315

Russo, J.; Sunjevaric, I.; Cayanis, E.; Rothstein, R.; Efstratiadis, A.; Fischer, S. 1993: Cosmid fingerprints for YAC contig identification and STS development. Cytogenetics and Cell Genetics 62(2-3): 104

Evans, G.A.; Lewis, K. 1989: Cosmid multiplex analysis for the construction of physical maps. Cytogenetics and Cell Genetics 51(1-4): 995

Berg, C.M.; Liu, X.; Carlo, A.; Yu, J.; Robertson, J.A. 1995: Cosmid restriction maps generated using pDUAL clones in drop-out mapping. Abstracts of the General Meeting of the American Society for Microbiology 95: 526

Craxton, M. 1993: Cosmid sequencing. Methods in Molecular Biology 23: 149-167

Datson, N.; Van Staalduinen, A.A.; Semina, E.; Murray, J.; Van Ommen, G.J.B.; Frants, R.R.; Den Dunnen, J.T. 1996: Cosmid-based exon trapping in the 4q25 region containing Rieger syndrome translocation breakpoints. European Journal of Human Genetics 4(Suppl 1): 85

Carey, A.H.; Halford, S.; Williamson, R.; Scambler, P.J. 1992: Cosmids from human chromosome 22 detect multiple loci that flank the dgs critical region. Journal of Cellular Biochemistry Suppl (16 Part F): 18

Breuning, M.H.; Dauwerse, H.; Saris, J.; Kievits, T.; Callen, D.F.; Van Ommen, G.J.B.; Pearson, P.L. 1989: Cosmids on the tip of chromosome 16p. Cytogenetics and Cell Genetics 51(1-4): 969-970

Bleecker, A.B.; Chang, C. 1990: Cosmids yacs and rflps walking to the hormone genes. Plant Physiology 93(1 Suppl): 40

Ratner, G.S.; Fofanov, V.I. 1989: Cosmization of science and problems of human exoecology. Ekologiya (Moscow) (3): 11-15

Joy, J.E.; Bunten, C.A. 1997: Cosmocercoides variabilis populations in the eastern American toad, Bufo a americanus from western West Virginia. Journal of the Helminthological Society of Washington 64(1): 102-105

Oro, J. 1998: Cosmochemical evolution A unifying and creative process in the Universe. Chela-Flores, J , Raulin, F Exobiology: Matter, energy, and information in the origin and evolution of life in the universe 11-32

Fleishman, D.G. 2008: Cosmogenic 22Na as an index of the residence time of water in freshwater basins: a review. Journal of Environmental Radioactivity 99(8): 1203-1215

Fleishman, D.G. 2008: Cosmogenic Na-22 as an index of the residence time of water in freshwater basins a review. Journal of Environmental Radioactivity 99(8): 1203-1215

Goel, P.S.; Kohman, T.P. 1962: Cosmogenic Carbon-14 in Meteorites and Terrestrial Ages of "Finds" and Craters. Science 136(3519): 875-876

Norton,K.P.; Blanckenburg,F.von; Schlunegger,F.; Schwab,M.; Kubik,P.W. 2008: Cosmogenic nuclide-based investigation of spatial erosion and hillslope channel coupling in the transient foreland of the Swiss Alps. Geomorphology: 3 4, 474-486

Waser, N.A.; Bacon, M.P.; Michaels, A.F. 1992: Cosmogenic phosphorus-32 and phosphorus-33 in rainwater and plankton off Bermuda and implications for phosphorus cycling. Falkowski, P G, Woodhead, A D Environmental Science Research; Primary productivity and biogeochemical cycles in the sea: 530-531

Borges,L.C.; Botelho,M.B. 2008: Cosmology an intangible heritage exhibition and educational programme at the Museum of Astronomy, Rio de Janeiro. International Journal Of Intangible Heritage: 56-70

Shaw, M.R. 1989: Cosmophorus cembrae new record ruschka for britain hymenoptera braconidae euphorinae. Entomologist's Gazette 40(3): 241-243

Glybin, L.Ya 1992: Cosmophysical aspects of diurnal cyclic recurrence Conception of temporal organization of human society. Biofizika 37(3): 559-565

Glybin, L.Yu 1992: Cosmophysical aspects of intradiurnal cyclicity concepts of the temporal organization of the life of human society. Biophysics (English Translation of Biofizika) 37(3): 466-472

Dmitriyevskii, I.M. 1993: Cosmophysical correlations in animate and inanimate nature as a manifestation of weak influences. Biophysics (English Translation of Biofizika) 37(4): 575-580, 1992

Moiseyeva, N.I. 1993: Cosmophysical fluctuations and the development of the human embryo. Biophysics (English Translation of Biofizika) 37(4): 601-605, 1992

Vladimirskii, B.M.; Kislovskii, L.D. 1995: Cosmophysical periods in European history. Biophysics (English Translation of Biofizika) 40(4): 849-852

Shih, C.T.; Chengalath, R. 1992: Cosmopolitanism in freshwater cyclopoid copepods Fact or fiction?. American Zoologist 32(5): 75A

Hernandez Garcia, M.; Diaz Morales, S.; Rodriguez Lopez, P.; Perez Padron, F. 1992: Cosmopolites sordidus new pest on banana crops in Canary Islands. Boletim da Sociedade Portuguesa de Entomologia 1992(139): 221

Sterling, P.H. 1997: Cosmopterix scribaiella Zeller new to the British Isles. Entomologist's Gazette 48(4): 205-207

Lee, L.S.; Rao, P.S.C.; Bellin, C.A.; Pinal, R. 1991: Cosolvent and ph effects on sorption of organic acids from methanol water mixtures. Abstracts of Papers American Chemical Society 202(1-2): ENVR 14

Silbiger, E.; Freeman, A. 1990: Cosolvent effect on dehydrogenase stability of gel entrapped viable microbial cells aerated vs non aerated processes. De Bont, J A M , Et Al Physiology Of Immobilized Cells; International Symposium, Wageningen, The Netherlands, December 10-13, 1989 Xv+716p Elsevier Science Publishers B V : Amsterdam, The Netherlands; (Dist For The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 295-300

Hardaway, L.A.; Yalkowsky, S.H. 1991: Cosolvent effects on diuron solubility. Journal of Pharmaceutical Sciences 80(2): 197-198

Chen, C.S.; Rao, P.S.resh C.; Delfino, J.J. 1997: Cosolvent effects on the dissolution of polynuclear aromatic hydrocarbons due to spills of oxygenated fuels in the subsurface environment. Abstracts of Papers American Chemical Society 213(1-3): ENVR 125

Singhai, A.K.; Jain, S.; Jain, N.K. 1996: Cosolvent solubilization and formulation of an aqueous injection of ketoprofen. Die Pharmazie 51(10): 737-740

Collina Girard, Jacques 1995: Cosquer cave Karstic evolution and prehistoric settlement. Comptes Rendus de l'Academie des Sciences Serie II A Sciences de la Terre et des Planetes 321(6): 561-567

Sunderland, N.R. 1996: Cosray The decommissioning. Health Physics 70(6 Suppl): S47

Allen, A.A. 1990: Cossonus linearis f coleoptera curculionidae in surrey and west kent england uk. Entomologist's Record and Journal of Variation 102(11-12): 300

Were, A.J.; McLigeyo, S.O. 1995: Cost consideration in renal replacement therapy in Kenya. East African Medical Journal 72(1): 69-71

Lohr, J.L.; Rocchini, A.P.; Hunter, D.W.; Hardin, J.T.; Bass, J.L. 1995: Cost Effectiveness of Coil Embolization of Patent Ductus Arteriosus. Journal of the American College of Cardiology 1995(SPEC ISSUE): 350A-351A

Gumnit, R.J. 1992: Cost accessibility and quality of life issues in surgery for epilepsy. Lueders, H O (Ed ) Epilepsy Surgery; Selected Papers And Meeting Reports From The Second International Cleveland Clinic Epilepsy Symposium, Cleveland, Ohio, Usa, June 1990 Xxvi+854p Raven Press: New York, New York, Usa Illus 47-49

Koontz, F. 1997: Cost accountable urine culture An opinion. Clinical Microbiology Newsletter 19(18): 142-143

Taylor, N.; Haddix, A.; Huggins, M. 1996: Cost analysis HIV/AIDS in the workplace Educational seminars in the Caribbean Island of St Kitts. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol One One world: One hope : 197-198

Davis, G.; Evangelista, A.T. 1997: Cost analysis and efficacy of CPS ID2 chromogenic medium for use in routine urine cultures. Abstracts of the General Meeting of the American Society for Microbiology 97: 132

Malmström, R.K.; Roine, R.P.; Heikkilä, A.; Räsänen, P.; Sintonen, H.; Muroma-Karttunen, R.; Honkanen, E. 2008: Cost analysis and health-related quality of life of home and self-care satellite haemodialysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(6): 1990-1996

Hamm, C.; Maccormick, R.; Wong, O. 1991: Cost analysis and quality of life evaluation of a peripheral cancer clinic in nova scotia canada. Clinical and Investigative Medicine 14(4 Suppl): A122

Slagel, D.D.; Raab, S.S. 1995: Cost analysis and utility of the gross and histologic examination of elective joint replacement tissue. Modern Pathology 8(1): 12A

Cunningham, V.L. 1994: Cost analysis as a pollution prevention tool. Waste Management 14(3-4): 309-315

Devoe, W.M.; Miller, J. 1991: Cost analysis for provision of neonatal pulmonary follow up care. Pediatric Research 29(4 Part 2): 254A

Pingsmann, A.; Müller, R.T.; Göller, A. 1998: Cost analysis for total hip arthroplasty by measurement of time and material expenditure. Archives of Orthopaedic and Trauma Surgery 117(8): 421-424

Lenisa, L.; Castoldi, R.; Socci, C.; Motta, F.; Ferrari, G.; Secchi, A.; Pozza, G.; Di Carlo, V. 1994: Cost analysis in kidney-pancreas vs simultaneous kidney-islet transplantation. Hormone and Metabolic Research 26(1): 71

Travers, E.M. 1990: Cost analysis in the toxicology laboratory. Clinics in Laboratory Medicine 10(3): 591-623

Turker, R.J.; Reyna, J.R. 1997: Cost analysis of DDH treatment based on age at presentation. Pediatrics 100(3 Part 2): 482-483

Koeppler, H.; Havemann, K. 1993: Cost analysis of G-CSF application after high dose cyclophosphamide, etoposide and BCNU and autologous bone marrow transplantation for poor prognosis malignant lymphoma. Annals of Hematology 67(Suppl ): A68

Sullivan, T.D. 1990: Cost analysis of a prepaid capitated managed care program for medicaid children. American Journal of Diseases of Children 144(4): 444

Klumpp, T.R.; Sullivan, E.M.; Ackerman, S.J.; Reblando, J.A.; Bleecker, G.C.; Mangan, K.F. 1998: Cost analysis of a randomized trial comparing G-CSF to standard supportive care following PBSC transplantation. Blood 92(10 Suppl 1 Part 1-2): 131A

Slaton, J.W.; Levy, D.A.; Morris, M.; Swanson, D.A.; Grossman, H.B.; Dinney, C.P.M. 1998: Cost analysis of a stage-specific approach to tumor surveillance after radical surgery for genitourinary neoplasms. Journal of Urology 159(5 Suppl): 302

Bowers, H.M.; House, P.J. 1998: Cost analysis of a telemedicine consultation. Journal of Investigative Medicine 46(1): 88A

Rhodes, R.J.; Hadley, N.H.; Baldwin, R.B.; Devoe, M.R.chard 1994: Cost analysis of a tidal-powered upwelling nursery system for juvenile clams. Journal of Shellfish Research 13(1): 286

Sharda, N.N.; Kinsella, T.J.; Ritter, M.A. 1995: Cost analysis of alternate management schemes in early state testicular seminoma. International Journal of Radiation Oncology Biology Physics 32(Suppl 1): 275

Cromwell, D.M.; Moore, R.D.; Brensinger, J.D.; Hamilton, S.R.; Petersen, G.M.; Bass, E.B.; Giardiello, F.M. 1997: Cost analysis of alternative screening approaches in familial adenomatous polyposis. Gastroenterology 112(4 Suppl): A10

Eisen, G.M.; Inadomi, J.M.; Sonnenberg, A. 1998: Cost analysis of alternative therapies for primary and secondary prophylaxis of variceal bleeding. Gastroenterology 114(4 Part 2): A589

Peberdy, M.A.; Overton, J.; Ornato, J.P. 1998: Cost analysis of an all-advanced life support emergency services system vs a two-tiered basic and advanced life support system The cost of the best is actually less. Circulation 98(17): I690

Hope, V.T.; Husain, A.M.; Mebust, K.A.; Nayer, M.A.; Radtke, R.A. 1996: Cost analysis of analog versus digital electroencephalography. Epilepsia 37(Suppl 5): 61

Benedetti, C.; Mcdonald, J.S.; Lingam, R.; Troutman, J. 1992: Cost analysis of cancer pain management with oral opioids. Anesthesiology 77(3A): A815

Bareket, Y.; Israel, M.L.; Lewis, P.A.; Horowitz, S.F. 1992: Cost analysis of cardiopulmonary resuscitation of patients with cardiac disease compared with those with other diagnoses. Clinical Research 40(3): 647A

Schoenike, S.E.; Wayne, A.S.; Pegelow, C.H. 1998: Cost analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood 92(10 Suppl 1 Part 1-2): 34B

Kearfott, K.J. 1990: Cost analysis of clinical positron emission tomography pet. Health Physics 58(Suppl 1): S19

Casanova, O.Q.; Behnke, M.; Eyler, F.D.; Conlon, M.; Woods, N.S. 1991: Cost analysis of cocaine exposed infants compared to controls matched on prenatal risk factors. Pediatric Research 29(4 Part 2): 252A

Sartore,S.; Lorenzetto,M.; Favero,L.; Ciaravino,G.; Cecchinato,M.; Bonfanti,L.; Marangon,S. 2008: Cost analysis of control measures for avian influenza outbreaks in Italy. Summa, Animali Da Reddito: 6, 29-36

Donohue, B.C.; O'neill, W.W.; Jackson, E.; Brodie, B.; Griffin, J.; Balestrini, C.; Stone, G.; Wharton, T.; Jones, D.E.; Grines, C.L. 1996: Cost analysis of different management strategies for myocardial infarction. Journal of the American College of Cardiology 27(2 Suppl A): 221A

Cheng, D.C.H.; Karski, J.; Peniston, C.; Asokumar, B.; Raveendran, G.; David, T.; Sandler, A.N. 1995: Cost analysis of early vs conventional extubation post coronary artery bypass graft surgery A prospective randomized controlled study. Anesthesia and Analgesia 80(2 Suppl): S73

Post, A.B.; Mulligan, D.C.; Bush, W. 1998: Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients. Transplantation Proceedings 30(5): 2102-2103

Lyman, G.H.; Lyman, C.G.; Sanderson, R. 1992: Cost analysis of hematopoietic growth factors hgfs in patients receiving cancer chemotherapy cc. Proceedings of the American Association for Cancer Research Annual Meeting 33: 241

Ackerman, S.J.; Klumpp, T.R.; Herman, J.H.; Guzman, G.I.; Goldberg, S.L.; Magdalinski, A.J.; Bleecker, G.C.; Mangan, K.F. 1996: Cost analysis of higher-dose versus lower-dose single donor platelet transfusions in peripheral blood stem cell and bone marrow transplant patients. Blood 88(10 Suppl 1 Part 1-2): 333A

Kendrick, A.H.; Wiltshire, N.; Catterall, J.R. 1997: Cost analysis of home oximetry versus full polysomnography in detecting obstructive sleep apnoea. European Respiratory Journal Suppl 10(25): 14S

Stern, Z.; Laufer, N.; Levy, R.; Ben-Shushan, D.; Mor-Yosef, S. 1995: Cost analysis of in vitro fertilization. Israel Journal of Medical Sciences 31(8): 492-496

Hilleman, D.E.; Mohiuddin, S.M.; Lucas, B.D.niel, J. 1993: Cost analysis of initial antihypertensive therapy. Circulation 88(4 Part 2): I263

Cara, J.F.; Basha, K.; Marvicsin, D.; Williams, P.; Nerenz, D. 1996: Cost analysis of inpatient versus outpatient management of children with newly diagnosed insulin-dependent diabetes mellitus. Pediatric Research 39(4 Part 2): 86A

Lenisa, L.; Castoldi, R.; Socci, C.; Motta, F.; Ferrari, G.; Pozza, G.; Di Carlo, V. 1995: Cost analysis of kidney-pancreas and kidney-islet transplant. Transplantation Proceedings 27(6): 3061-3064

Fulgham, P.F.; Feagins, B.A.; Cochran, J.S.; Kadesky, M.C.; Denman, J.L.; Harrison, C.B. 1993: Cost analysis of laparoscopic lymphadenectomy in a private practice setting. Journal of Urology 149(4 Suppl): 412A

Gupta, P.; Leroy, S.C.; Bateman, A.; Morrison, V.A. 1998: Cost analysis of long-term blood product transfusion support for patients with myelodysplastic syndromes. Blood 92(10 Suppl 1 Part 1-2): 421A

Levy, E. 1989: Cost analysis of osteoporosis related to untreated menopause. Clinical Rheumatology 8(Suppl 2): 76-82

Menne, R.; Adolph, M.; Brock, E.; Schneider, H.; Senkal, M. 2008: Cost analysis of parenteral nutrition regimens in the intensive care unit: three-compartment bag system vs multibottle system. JPEN. Journal of Parenteral and Enteral Nutrition 32(6): 606-612

Nakada, S.Y.; Saywell, R.M.; Lingeman, J.E.; Woods, J.R.; Robinson, R.L.; Group, L.P.le Study 1997: Cost analysis of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy for the treatment of lower pole nephrolithiasis. Journal of Endourology 11(Suppl 1): S146

Warwick, A.B. 1998: Cost analysis of peripheral versus bone marrow stem cells in autologous bone marrow transplantation. Blood 92(10 Suppl 1 Part 1-2): 374B

Quarello, F.; Vanara, F.; Formica, M.; Bonello, F.; Martina, G.; Boero, R.; Basolo, B.; Guarena, C.; Piccoli, G.P. 1992: Cost analysis of peritoneal dialysis versus other treatments in a single unit. Ota, K, Maher, J, Winchester, J, Hiszel, P International Congress Series; Current concepts in peritoneal dialysis: 830-835

Irazuzta, J.; Allen, B.; Arnold, F. 1994: Cost analysis of physician originated expenses for tests in patients with meningoencephalitis in a PICU. Pediatric Research 37(4 Part 2): 47A

Ghalib, Reem H.; Al Assi, Mohammad T.; Clark, James H.; Shokor, Nada; Ankoma Sey, Victor; Galati, Joseph S.; Ozaki, Claire F.; Wood, Patrick 1998: Cost analysis of post liver transplant infections. Hepatology 28(4 Part 2): 357A

Bengtson, S.; Borgquist, L.; Lidgren, L. 1989: Cost analysis of prophylaxis with antibiotics to prevent infected knee arthroplasty. Bmj 299(6701): 719-720

Bolivar,P.A.; MaldonadoEstrada,J.G. 2008: Cost analysis of protocols for transfer of bovine embryos used in Colombia. Revista Colombiana De Ciencias Pecuarias: 3, 351-364

Peberdy, M.A.; Ornato, J.P. 1998: Cost analysis of providing widespread early defibrillation at major league athletic events It costs less than peanuts or Cracker-Jacks. Circulation 98(17): I174

Geurtsen, M.; Greene, D.; Floss, A.; Strauss, R.G. 1996: Cost analysis of quality improvement initiatives. Transfusion 36(9 Suppl): 84S

Noyes, W.R.; Auchter, R.M.; Craig, B.; French, M.C.; Johnson, M.N.; Lamond, J.P.; Levin, A.B.; Kinsella, T.J.; Mehta, M.P. 1996: Cost analysis of radiosurgery versus resection for single brain metastases. Kondziolka, D Radiosurgery, Vol 1; Radiosurgery 1995 172-179

Maclean, C.H.; Keeler, P.P.L.e And Emmett, B. 1996: Cost analysis of routine ophthalmologic screening for hydroxychloroquine retinal toxicity. Arthritis and Rheumatism 39(9 Suppl): S72

Miller, D.D.; Taillefer, R.; Heller, G.V.; Shaw, L.J. 1996: Cost analysis of stress myocardial perfusion imaging in 4,638 women with stable angina Comparison to a strategy of direct coronary angiography. Journal of Nuclear Medicine 37(5 Suppl): 68P-69P

Mathews, R.; Docimo, S. 1997: Cost analysis of the treatment of vesicoureteric reflux A computer model. Pediatrics 100(3 Part 2): 557

Bibo, J.C.; Engel, G.L.; Kootstra, G.; Daemen, J.H. 1995: Cost analysis of transplantation with ischemically damaged kidneys: preliminary results. Transplantation Proceedings 27(5): 2959

Aboel Nasr, Mamdouh; El Galley, Rizk E.S.; Saleem, Mohamad D.; Sanders, Holt W. 1997: Cost analysis of transrectal ultrasonographic guided biopsy in post-prostatectomy patients. Journal of Urology 157(4 Suppl): 57

Imai, H. 1998: Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation. Hokkaido Journal of Medical Science 73(2): 137-145

Hammond, Max Ward 1993: Cost analysis of variable fertility management of phosphorus and potassium for potato production in central Washington. Robert, P C, Rust, R H, Larson, W E Soil specific crop management: A workshop on research and development issues: 213-228

Launbjerg, L.; Fruergaard, P.; Berning, J.; Eliasen, P.; Borch Johnsen, K.; Eiken, P.A. 1990: Cost and benefit by early discharge of low risk patients after acute myocardial infarction by echocardiographic guidance. European Heart Journal 11(ABSTR Suppl): 195

Mattei, J.H. 1992: Cost and benefits of chemical defense production in brassica cultivars. Bulletin of the Ecological Society of America 73(2 Suppl): 264

O'shea, T.M.; Sevick, M.A.; Givner, L.B. 1997: Cost and benefits of prophylaxis of very low birth weight infants with respiratory syncytial virus immune globulin. Pediatric Research 41(4 Part 2): 207A

Locke, J.L. 2008: Cost and complexity: selection for speech and language. Journal of Theoretical Biology 251(4): 640-652

Wever, E.F.D.; Hauer, R.N.W.; Ramanna, H.; Van Capelle, F.J.L.; Crijns, H.J.G.M.; Algra, A.; Robles, D.M.dina, E.O. 1995: Cost and cost-effectiveness of implantable defibrillator as first-choice therapy versus conventional strategy in post-infarct sudden death survivors A randomized study. European Heart Journal 16(ABSTR Suppl ): 262

Brooker,S.; Kabatereine,N.B.; Fleming,F.; Devlin,N. 2008: Cost and cost-effectiveness of nationwide school-based helminth control in Uganda intra-country variation and effects of scaling-up. Health Policy And Planning: 1, 24-35

Rosen, S.; Long, L.; Fox, M.; Sanne, I. 2008: Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. Journal of Acquired Immune Deficiency Syndromes 48(3): 334-344

Whitlock, R.M.L. 1993: Cost and effectiveness of DDD pacing at Green Lane Hospital. COMMITTEE OF THE ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING and ELECTROPHYSIOLOGY Author Symposium on Cardiac Pacing and Electrophysiology: Cardiac pacing and electrophysiology today: A new era of therapeutic arrhythmology 188-191

Carlsson, P.; Tiselius, H.G. 1989: Cost and effectiveness of extracorporeal shock wave lithotripsy. Scandinavian Journal of Urology and Nephrology. Supplementum 122: 34-43

John, K.R.; Muliyil, J. 1993: Cost and effectiveness of integrating leprosy with primary care. International Journal of Leprosy and Other Mycobacterial Diseases 61(4 Suppl): 41A

Hlatky, M.A. 1996: Cost and efficacy analysis in the ESVEM trial: implications for diagnosis and therapy for ventricular tachyarrhythmias. Progress in Cardiovascular Diseases 38(5): 371-376

Thomas, P.; Ross, R. 1995: Cost and efficacy analysis of the effect of adding nedocromil sodium to the treatment of asthma patients. European Respiratory Journal 8(Suppl 19): 47S

Hillner, B.E.; Bear, H.D.; Smith, T.J. 1995: Cost and efficacy trade-offs of surgical biopsy vs stereotactic breast biopsy in women with nonpalpable mammographically detected lesions. Jgim 10(4 Suppl): 52

Ko, S.H.; Sun, S.C. 1993: Cost and efficiency of performing 5 common laboratory tests in NICU Conventional vs instant. Pediatric Research 33(4 Part 2): 219A

Lubin, B.; Sherer, R.; Cohen, M.; Pulvirenti, M.; Weber, K.; Orange, E.; Goodwin, E.; Zimmerman, S.; Straight, C.; Booth, C.; Cohen, G.; Jasek, J.; Pearson, K. 1996: Cost and effort of recruitment and retention in minority and female clinical trials and natural history studies. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol Two One world: One hope : 84

Floyd, K.; Gilks, C. 1997: Cost and financing aspects of providing antiretroviral therapy. van Praag, E, Fernyak, S, Katz, A M The implications of antiretroviral treatments 63-78

Fylling, C.P.; Mckeown, P.C. 1990: Cost and healing efficacy of treating diabetic foot ulcers in a wound management program with growth factor therapy. Diabetologia 33(Suppl): A169

Steen Carlsson, K.; Astermark, J.; Donfield, S.; Berntorp, E. 2008: Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor. Thrombosis and Haemostasis 99(6): 1060-1067

Gordon, T.A.; Burleyson, G.P.; Shahrokh, S.; Bass, E.B.; Cameron, J.L. 1996: Cost and outcome for complex high-risk gastrointestinal surgical procedures. Surgical Forum 47: 618-620

Wachter, R.M.; Luce, J.M.; Scitovsky, A.A. 1992: Cost and outcome of intensive care for patients with aids pneumocystis carinii pneumonia and respiratory failure. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : d471

Kaygisiz,F.; Ograk,Y.Z. 2008: Cost and productivity analysis for puppy production in Kangal race dog production companies in Sivas. Journal Of Animal And Veterinary Advances: 10, 1273-1275

Roscoe, J.M.; Raisbeck, A.; Brissenden, J.; Mudge, B. 1993: Cost and quality Dialysis in long term care facility. Journal of the American Society of Nephrology 4(3): 379

Naidu,V.; Aguilera,J.F.; Beer,J.de; Netshipale,P.; Harris,G. 2008: Cost and quality performance indicators for home community-based care services to orphans and vulnerable children. South African Journal Of Economics: Suppl

RamSuresh; Singh,H.L. 2008: Cost and return structure of sugarcane- livestock based farming system in Gonda district of Uttar Pradesh. International Journal Of Agricultural Sciences: 2, 477-479

Nchinda,V.P.; Mendi,S.D.; Imele,H.; Kamga,P.; Ngassam,S.B.; Chi,C.M. 2008: Cost and returns of smallholder yoghurt production enterprises in the Western highlands of Cameroon. Journal Of Applied Biosciences: 1, 372-377

Morris, A.J.; Smith, L.K.; Smith, P.J.; Mirrett, S.; Reller, L.B. 1994: Cost and time savings following specimen rejection criteria. Abstracts of the General Meeting of the American Society for Microbiology 94: 519

Bailes, J.S. 1995: Cost aspects of palliative cancer care. Seminars in Oncology 22(2 Suppl 3: 64-66

Goourey, S.; Aguirre, M.; Kouame, T.; Togbe, T.; Ekrakou, R. 1996: Cost assessment of out-patient AIDS treatment in an ONG medical facility in Abidjan, Ivory Coast. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol Two One world: One hope : 272

Woods, J.E. 1989: Cost avoidance and productivity in owning and operating buildings. Occupational Medicine 4(4): 753-770

Eisenstein, E.L.; Newby, L.K.; Knight, J.D.; Shaw, L.J.; Califf, R.M.; Topol, E.J.; Mark, D.B. 1996: Cost avoidance through early discharge of the uncomplicated acute myocardial infarction patient. Journal of the American College of Cardiology 27(2 Suppl A): 244A-245A

Shapiro, D.I.; Schneider, M.S.; Lewis, R.J. 1994: Cost awareness among anesthesiology residents and faculty. Anesthesiology 81(3A): A1203

Goldman, L. 1991: Cost awareness in medicine. Wilson, J D , Et Al (Ed ) Harrison's Principles Of Internal Medicine, Twelfth Edition, Vols 1 And 2 Xxx+1026p (Vol 1); Xxx+1183p (Vol 2) Mcgraw-Hill, Inc : New York, New York, Usa; London, England, Uk Illus Maps 11-16

Rothengatter, W. 1991: Cost benefit analyses for goods transport on roads. Kroon, M , R Smit And J Van Ham (Ed ) Studies in Environmental Science, 45 Freight Transport And The Environment Xiii+355p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus Maps 187-213

Polk, S.L.; Roizen, M.F. 1990: Cost benefit analysis in monitoring. Blitt, C D (Ed ) Monitoring in Anesthesia And Critical Care Medicine, Second Edition Xix+903p Churchill Livingstone Inc : New York, New York, Usa; Edinburgh, Scotland, Uk Illus 65-78

Latham, N.; Dudfield, M.; Bodansky, H.J. 1997: Cost benefit analysis of a physical activity programme for patients with NIDDM. Diabetologia 40(Suppl 1): A254

AnwarHussain; Naeem-ur-RehmanKhattak; Khan,A.Q. 2008: Cost benefit analysis of different rice varieties in district Swat. Sarhad Journal Of Agriculture: 4, 745-748

Sullivan, B.J.; Desbiens, N.A.; Layde, P.M. 1989: Cost benefit analysis of four conjugate hib vaccines using a markov cohort approach. Pediatric Research 25(4 Part 2): 192A

L.G.les C.; Seror, V.; Courpotin, C.; Tricoire, J.; Reynert, P.; Diakate, F. 1992: Cost benefit analysis of hiv prenatal screening in france. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : c380

Hillman, A.L.; Bloom, B.S. 1989: Cost benefit analysis of misoprostol in the prevention of gastric ulcer implications in actual clinical use. Arthritis and Rheumatism 32(4 Suppl): S100

Makela, P.H. 1995: Cost benefit analysis of pneumococcal vaccination. Mayon-White, R T Royal Society of Medicine International Congress and Symposium Series; The clinical impact of pneumococcal disease and strategies for its prevention 41-47

Sonnenberg, A.; Townsend, W.F. 1991: Cost benefit analysis of preoperative testing for fecal occult blood. Gastroenterology 100(5 Part 2): A19

Barker, J.S.; Griffith, M.J.; Mccomb, J.M. 1994: Cost benefit analysis of radiofrequency ablation of accessory pathways. European Heart Journal 15(ABSTR Suppl ): 270

Guaschino, S.; Spinillo, A.; Prinetti, I.; Pistoni, A. 1990: Cost benefit analysis of screening and therapy of chlamydia trachomatis infections. Genazzani, A R , F Petraglia And A Volpe (Ed ) Progress in Gynecology And Obstetrics; Second European Winter Conference in Gynecology And Obstetrics, Madonna Di Campiglio, Italy, March 1989 Xxvi+944p Parthenon Publishing Group: Carnforth, England, Uk; Park Ridge, New Jersey, Usa Illus 285-288

Crespi, M.; Caperle, M. 1992: Cost benefit analysis of screening for colorectal cancer article eight in the series. Practical Gastroenterology 16(4): 16G-16H, 16J, 16L-16M

Domingo, E.; Bermejo, B.; Riera, J.C.; Aguade, S.; Olona, M.; Vaque, J. 1992: Cost benefit analysis of several prognostic strategies after a non complicated myocardial infarction. European Heart Journal 13(ABSTR Suppl): 306

Sheingold, S.H. 1990: Cost benefit analysis of using recombinant human erythropoietin for the anemia of chronic renal failure. Kidney International 37(1): 520

Porath, A.; Mcnutt, R.A.; Smiley, L.M.; Weigle, K.A. 1990: Cost benefit and effectiveness of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Public Health Reviews 17(1): 74

Stephan, M.; Baker, R.C.; Bausher, J.C. 1990: Cost benefit and procedure benefit analysis of infants at risk for occult bacteremia. American Journal of Diseases of Children 144(4): 422

Guazzoni, G.; Montorsi, F.; Consonni, P.; Trimboli, F.; Rigatti, P. 1995: Cost benefit assessment of surgical therapy for benign prostatic hyperplasia in the DRG ERA. Journal d'Urologie 101(1): 55

Nutter, F.W.Jr; Mills, F.D. 1990: Cost benefit comparison of a weather based fungicide scheduling program versus a calendar spray program to control late leafspot of peanut. Phytopathology 80(10): 989

Modell, B. 1991: Cost benefit considerations and social aspects of genetic services. American Journal of Human Genetics 49(4 Suppl): 31

Kezaala, E.R.; Needham, H.; Duggan, M. 1992: Cost benefit evaluation in aids care delivery a case study of nsambya hospital uganda. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : d470

Hadler, S.C. 1994: Cost benefit of combining antigens. Biologicals: Journal of the International Association of Biological Standardization 22(4): 415-418

Bolin, T.D. 1996: Cost benefit of early diagnosis of colorectal cancer. Scandinavian Journal of Gastroenterology. Suppl 220: 142-146

Hindi Alexander, M.; Zielezny, M.; Reynolds, R.; Throm, T.; Polinski, J.; Middleton, E.Jr 1990: Cost benefit of home peak flow meters and education in the buffalo adult asthma program baap. American Review of Respiratory Disease 141(4 Part 2): A496

Landenburger, G.; Kennedy, B.H. 1991: Cost benefit of newborn sickle cell screening and treatment programs. American Journal of Human Genetics 49(4 Suppl): 321

Tanprasert, S. 1996: Cost benefit of using HIV antigen test for blood screening. Vox Sanguinis 70(Suppl 2): 9

Yeo, G.S.H.; Lai, F.M. 1991: Cost benefit projection of a down syndrome screening programme using maternal age maternal serum alpha fetoprotein value and femur length of fetus on ultrasound. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 509

Kerleau, M.; Lanoe J L.; Nalpas, B. 1990: Cost benefit study of hepatitis b vaccination a matter of methods. Dphm/Inserm (Directeur De La Pharmacie Et Du Medicament/Institut National De La Sante Et De La Recherche Medicale) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 213 L'europe Du Medicament: Realites Et Ambitions; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 213 Europe And Drugs: Realities And Ambitions); Fourth Colloquium Of The Dphm-Inserm (Director Of Pharmacy And Drugs And National Institute Of Health And Medical Rese

Hanley, S.P.; Johnson, S.C. 1995: Cost benefits of an assessment programme for provision of domiciliary nebulised bronchodilators. European Respiratory Journal 8(Suppl 19): 317S

Hashiguchi, M.; Yamauchi, N.; Uchikura, T.; Mochizuki, M. 2008: Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 128(4): 585-594

Woronoff Lemsi, M.C.; Limat, S.; Deconinck, E.; Arveux, P.; Cahn, J.Y. 1995: Cost comparative study of peripheral blood progenitor cells and autologous bone marrow transplantation for lymphomas patients. Blood 86(10 Suppl 1): 209A

Pagotto, L.T.; Mullins, C.E.; Hellenbrand, W.E.; Latson, L.A.; Cheatham, J.P. 1994: Cost comparative study of surgical vs transcatheter closure of isolated patent ductus arteriosus. Circulation 90(4 Part 2): I642

Helal, M.; Mastandrea, F.; Black, T.; Lockhart, J. 1995: Cost comparison and effectiveness between ESWL and percutaneous nephrolithotripsy in the management of staghorn calculi. Journal of Urology 153(4 Suppl): 284A

Urdahl, S.G.; Zeman, J.D. 1997: Cost comparison of automated double red blood cell collection and whole blood products. Transfusion 37(9 Suppl): 115S

Noorani, H.Z.; Berk, T.; Detsky, A.S.; Gallie, B.L.; Cohen, Z.; Gallinger, S.; Bapat, B. 1995: Cost comparison of conventional vs molecular screening for familial adenomatous polyposis. American Journal of Human Genetics 57(4 Suppl): A297

Gladman, J.; Whynes, D.; Lincoln, N. 1994: Cost comparison of domiciliary and hospital-based stroke rehabilitation. DOMINO Study Group. Age and Ageing 23(3): 241-245

Vandormael, M.; Reifart, N.; Preusler, W.; Stoerger, H.; Schwartz, F.; Hofmann, M.; Kloepper, J.W.; Mueller, S. 1993: Cost comparison of excimer laser, rotablator and balloon angioplasty for treatment of complex coronary lesions A randomized prospective trial. European Heart Journal 14(ABSTR Suppl ): 76

Thomas, P.A.; Ferguson, D.J.; Raab, S.S. 1994: Cost comparison of fine needle aspiration biopsy and surgical excision in the workup for superficial lymphadenopathy. Acta Cytologica 38(5): 867

Gardner, M.; Rouse, D.; Goldenberg, R.; Lanning, J.; Thom, E.; Zachary, J. 1996: Cost comparison of induction of labor at 41 weeks versus expectant management in the post-term pregnancy. American Journal of Obstetrics and Gynecology 174(1 Part 2): 351

Mackey, T.J.; Flowers, J.L.; Bartlett, S.T.; Cho, E.; Jacobs, S.C.; Naslund, M.J. 1997: Cost comparison of laparoscopic versus open donor nephrectomy analyzing provider charges and productivity loss. Journal of Urology 157(4 Suppl): 156

Bonzani, R.A.; Stricker, H.J.; Peabody, J.O.; Fugate, D.; Cerny, J.C. 1996: Cost comparison of lupron and orchiectomy. Journal of Urology 155(5 Suppl): 454A

Naslund, M.J.; Stitcher, M.F. 1994: Cost comparison of medical management and surgical prostatectomy for BPH. Journal of Urology 151(5 Suppl): 268A

Hunter, C.; Katz, B.; Loehrer, P.; Vance, G.H. 1997: Cost comparison of medical screening versus molecular testing of individuals at risk for inheriting an adenomatous polyposis coli gene mutation. American Journal of Human Genetics 61(4 Suppl): A221

Joshi, G.P.; Garg, S.A.; Yu, S.Y. 1996: Cost comparison of mivacurium and rocuronium for ambulatory anesthesia. Anesthesiology 85(3A): A1034

Apostolidou, I.; Despotis, G.J.; Skubas, N.; Hogue, C.W.; Triantafillou, A.N.; Lappas, D.G. 1996: Cost comparison of nicardipine and nitroglycerin infusion in cardiac surgery. Anesthesiology 85(3A): A114

Bapat, B.; Berk, T.; Noorani, H.Z.; Mitri, A.; Xia, L.; Gallie, B.L.; Detsky, A.S.; Gallinger, S.; Cohen, Z. 1997: Cost comparison of predictive genetic testing vs clinical screening for familial adenomatous polyposis. Gastroenterology 112(4 Suppl): A535

Eckleberg, T.; Vlietstra, R.E.; Brenner, A.S.; Grines, C.L.; O'neill, W.W.; Browne, K.F. 1992: Cost comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Clinical Research 40(4): 806A

Mehta, M.; Noyes, W.; Levin, A.; Kinsella, T. 1994: Cost comparison of radiosurgery and surgery for treatment of brain metastasis. International Journal of Radiation Oncology Biology Physics 30(Suppl 1): 265

Murray, B.M.; Blas, S. 1997: Cost comparison of two approaches to the management of CMV infection in renal transplant recipients. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 695A

Chircus, J.; Stone, N.N. 1997: Cost comparisons between radical prostatectomy, external beam radiation therapy, brachytherapy and cryoablation. Journal of Urology 157(4 Suppl): 155

Adrian, J.L.; Montgomery, C.C.; Behe, B.K.; Tilt, K.M.; Duffy, P.A. 1997: Cost comparisons of three tree species using three alternative production methods. HortScience 32(4): 594

Ricotta, J.J.; O'brien Irr, M.S. 1997: Cost concerns in carotid surgery. Calligaro, K D, DeLaurentis, D A, Baker, W H Management of extracranial cerebrovascular disease: 3-13

Greenberg, C.P.; Wald, A.; Roth, J.M. 1994: Cost conscious anesthetic choice for ambulatory surgery. Anesthesiology 81(3A): A1202

Russell, S.; Griffin, D.; Hume, R.; Wagner, R.; Calhoun, B. 1998: Cost consequences of implementation of the group B streptococcus risk assessment treatment guidelines at a military teaching hospital. American Journal of Obstetrics and Gynecology 178(1 Part 2): S121

Markman, M. 1990: Cost considerations in the peer reviewed medical literature significant variation by individual journal and subspeciality. Clinical Research 38(2): 513A

Sheps, S.G. 1990: Cost considerations of ambulatory blood pressure monitoring. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 8(6): S29-S31

Burbidge, A.A. 1991: Cost constraints on surveys for nature conservation. Margules, C R And M P Austin (Ed ) Nature Conservation: Cost Effective Biological Surveys And Data Analysis; Workshop on Cost Effective Survey Methods For Nature Conservation, Sydney, New South Wales, Australia, March 1988 Vii+207p Csiro: East Melbourne, Victoria, Australia Illus Maps 3-6

Tilford, J.M.; Roberson, P.K.; Robbins, J.M.; Fiser, D.H. 1994: Cost containment and clinical performance in pediatric intensive care. Pediatric Research 37(4 Part 2): 56A

Cowan, J.A.; Verghese, A. 1990: Cost containment and cost effective antibiotic therapy in the nursing home. Verghese, A And S L Berk (Ed ) Infections in Nursing Homes And Long-Term Care Facilities Xvi+248p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 221-230

Valantine, H.; Keogh, A.; Mcintosh, N.; Hunt, S.; Oyer, P.; Schroeder, J. 1990: Cost containment coadministration of diltiazem with cyclosporine following cardiac transplantation. Journal of Heart Transplantation 9(1): 68

Schmidt, C.J.; Balu, D.; Beam, T.R. 1993: Cost containment in the microbiology lab via elimination of routine anaerobic blood cultures. American Journal of Clinical Pathology 100(3): 341

Weiner, S.; Carter, J. 1993: Cost containment in the operating room The role of physician education. Anesthesiology 79(3A): A533

Digiacomo, J.C.; Odom, J.W.; Ritota, P.C.; Swan, K.G. 1991: Cost containment in the operating room use of reusable vs disposable clothing. Clinical Research 39(2): 410A

Fuchs, A.M. 1993: Cost containment in ureteroscopic lithotripsy. Journal of Endourology 7(Suppl 1): S96

May, O. 1989: Cost containment insurance reimbursement and drug research. Drugs Made in Germany 32(1): 1-2, 4-6

Treleaven, S.; Einarson, T.R. 1990: Cost containment measures in hospital pharmacy: a bibliography. Canadian Journal of Hospital Pharmacy 43(1): 17-25

Weiss, E.P.; Allison, D. 1995: Cost containment of acute work-related injuries An evaluation of a cost reduction measure. Clinical and Investigative Medicine 18(4 Suppl): B121

Morris, P.B.; Hawver, J. 1991: Cost containment of major ano rectal surgery by use of outpatient carbon dioxide laser. Lasers in Surgery and Medicine (Suppl 3): 20

Herold, T.J.; Hung, J.C. 1995: Cost containment techniques to reduce radiopharmaceutical expenseS in nuclear medicine department. Journal of Nuclear Medicine 36(5 Suppl): 260P

Deyo, R.A.; Cherkin, D.; Conrad, D.; Volinn, E. 1991: Cost, controversy, crisis: low back pain and the health of the public. Annual Review of Public Health 12: 141-156

Schapira, D.V.; Jarrett, A.R. 1995: Cost diagnosis and survival of patients with unknown primary cancer. Journal of Investigative Medicine 43(Suppl 1): 33A

Whang, W.; Sisk, J.E.; Pogue, V.; Francis, C.K. 1995: Cost differences among drug therapies to manage hypertension in African-Americans. Jgim 10(4 Suppl): 85

Satpute,A.A.; Kadam,U.S.; Gadge,S.B.; Dhotre,R.S. 2008: Cost economics of cucumber as influenced by fertigation through drip. Journal Of Maharashtra Agricultural Universities: 3, 347-350

Kay, K.; Cosnett, M. 1996: Cost effective AIDS awareness programme on commercial farms in Zimbabwe. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 45

Surkin, K.; Hershberger, D. 1997: Cost effective QC designed with the Westgard Validator and computer simulation. Clinical Chemistry 43(6 Part 2): S140-S141

Gambhir, S.S.; Shepherd, J.; Shah, B.D.; Schwimmer, J.; Czernin, J.; Phelps, M.E. 1998: Cost effective analysis modeling for the role of FDG coincidence imaging in the management of patients with a solitary pulmonary nodule. Journal of Nuclear Medicine 39(5 Suppl): 248P-249P

Gambhir, S.S.; Emi, T.; Hart, E.; Hoh, C.; Allen, M.; Hendi, P.; Phelps, M.E. 1996: Cost effective analysis modeling of the role of FDG PET in the management of patients with a solitary pulmonary nodule. Journal of Nuclear Medicine 37(5 Suppl): 110P-111P

Gambhir, S.S.; Valk, P.; Shepherd, J.; Hoh, C.; Allen, M.; Phelps, M.E. 1997: Cost effective analysis modeling of the role of FDG PET in the management of patients with recurrent colorectal cancer. Journal of Nuclear Medicine 38(5 Suppl): 90P-91P

Clark, R.F.; Williams, S.R.; Nordt, S.P.; Manoguerra, A.S. 1996: Cost effective analysis of a toxicology consultation service. Journal of Toxicology. Clinical Toxicology 34(5): 580-581

Moody, J.; Olson, D. 1993: Cost effective biochemical screens for potential Salmonella and Shigella from stool Is faster better?. Abstracts of the General Meeting of the American Society for Microbiology 93: 498

Child, L.; Wade, M.; Wagner, M. 1998: Cost effective control of Fallopia japonica using combination treatments. Starfinger, U, Edwards, K, Kowarik, I, Williamson, M Plant invasions: Ecological mechanisms and human responses 143-154

Taverner, P.D. 1991: Cost effective control of redlegged earth mite and lucerne flea in annual medic pastures. Ridsdill-Smith, J (Ed ) Proceedings Of A National Workshop on Redlegged Earth Mite, Lucerne Flea And Blue Oat Mite; Meeting, Perth, Western Australia, Australia, September 9-11, Vii+169p Department Of Agriculture: South Perth, Western Australia, Australia Illus Maps Paper 57-59

Mauldin, J.G.; Newman, R.B.; Durkalski, V.L.; Mauldin, P.D. 1998: Cost effective delivery management of the vertex/non-vertex twin gestation. American Journal of Obstetrics and Gynecology 178(1 Part 2): S15

Wason, S.K.; Sumpter, J.E. 1998: Cost effective dental compositions containing novel sodium aluminosilicates. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 378

Labombardi, V.J.; Cataldo Caputzal, L.; Mayer, F. 1995: Cost effective determination of E coli bacteriuria utilizing a MacConkey-MUG/ modified CLED Urine dipslide. Abstracts of the General Meeting of the American Society for Microbiology 95: 67

Clarke, W.N.Sr; Hodges, E.; Ooten, R.J. 1990: Cost effective dewatering of municipal treatment plant sludges using belt presses. Water Science and Technology 22(12): 173-182

Gueye, A.; Kanki, P.; Samuels, K.; Mboup, S.; Marlink, R.; Papas, T.; Essex, M. 1992: Cost effective diagnosis of hiv 1 and hiv 2 infection by recombinant proteins. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : c317

Lee J.T.; Li P.K. 1992: Cost effective emit methods for four anticonvulsants and theophylline performed on synchron cx4. Clinical Chemistry 38(6): 1013

Kohan, A.D.; Armenakas, N.A.; Fracchia, J.A. 1997: Cost effective hydrocele ablation. Journal of Urology 157(4 Suppl): 157

Kaminski, D.A.; Casiano Colon, A.E.; Weymouth, L.A. 1991: Cost effective identification of mycobacteria isolated from blood. Abstracts of the General Meeting of the American Society for Microbiology 91: 148

Whittier, S.; Della Latta, P. 1996: Cost effective laboratory practices for the detection of C difficile toxin. Abstracts of the General Meeting of the American Society for Microbiology 96: 63

Senak, M.S. 1993: Cost effective legal services in large community based organizations. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 917

Hanson, V.; Nadijcka, M.; Eleazer, S.; Williams, B. 1995: Cost effective management of diabetic foot ulcers. Strauss, M S Unity in Diversity: Pagination varies ABSTRACTS 142

Jobes, D.R.; Elzioni, D.A.; Stepsis, L.H.; Dzien, K.E.; Choy, Y.; Mancini, J. 1996: Cost effective management of heparin/protamine in CP bypass surgery Analysis by type of surgery. Anesthesiology 85(3A): A147

Budiman Mak, E.; Songsiridej, N.; Lertratanakul, Y.; Roach, K. 1989: Cost effective management of the painful shoulder. Arthritis and Rheumatism 32(4 Suppl): S97

Whittier, S.; Magparangalan, C.; Della Latta, P. 1997: Cost effective methodology for determination of antinuclear antibodies. Abstracts of the General Meeting of the American Society for Microbiology 97: 574

Kurtin, P.; Roche, P. 1993: Cost effective phenotyping of T-cell lymphomas in paraffin sections. Laboratory Investigation 68(1): 138A

Barritt, M.; Little, J.; Gregoire, H. 1997: Cost effective practices utilizing antigen specific enzyme immunoassays for diagnosis of parasitic infections. Abstracts of the General Meeting of the American Society for Microbiology 97: 135

Gratch, D.M.; Bell, S.; Witkowski, T. 1997: Cost effective preoperative testing An anesthesiologist directed approach. Anesthesiology 87(3 Suppl): A1011

Trainor, B.P.; Kernohan, W.G.; Carson, N.; Mollan, R.A.B. 1989: Cost effective screening for congenital dislocation of the hip. Physics in Medicine and Biology 34(1): 139-140

Arbuckle, K.; Aikey, S.; Resek, C.N.; Kellogg, J.A.; Sautter, R.L. 1989: Cost effective shell vial technique for detection of herpes simplex virus. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 395

Mantovani, L.; Liebmann, A.; Engel, C.; Lehmann, T.; Niedewieser, D.; Loeffler, M. 1998: Cost effective short term G-CSF treatment in 2-weekly CHOP regimens for patients with aggressive NHL. Blood 92(10 Suppl 1 Part 1-2): 178B

Madar, I.; Hoh, C.; Figlin, R.A.; Holmes, C.E.; Waters, P.F.; Gambhir, S.S.; Phelps, M.E.; Maddahi, J. 1995: Cost effective staging of non-small cell lung carcinoma by whole body PET FDG imaging. Journal of Nuclear Medicine 36(5 Suppl): 57P-58P

Lovchik, J.; Hudson, J.; Hebel, R.; Alger, L. 1992: Cost effective strategies for managing chlamydial infection in pregnancy. Abstracts of the General Meeting of the American Society for Microbiology 92: 110

Robinson, A.; Binns, L. 1989: Cost effective transport of specimens for anaerobic culture in compliance with universal precautions. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 440

Coroneo, M.T.; Morlet, N.; Young, S.H.; Naidoo, D.; Fong, T. 1995: Cost effective treatment of CMV retinitis with high-dose intravitreal ganciclovir. IOVS Investigative Ophthalmology and Visual Science 36(4): S322

Lightfoot, R.W. 1997: Cost effective use of laboratory tests in rheumatology. Bulletin on the Rheumatic Diseases 46(6): 1-3

Rubenstein, J.S.; Colin, W.; Jackson, D.; Lockwood, C.; Molloy, J.; Marx, L.M. 1997: Cost effective use of muscle relaxants A decision analysis. Pediatrics 100(3 Part 2): 451-452

Morgan, M.A.; Hardy, J. 1997: Cost effective use of rapid urease medium in diagnosing H pylori gastritis. Abstracts of the General Meeting of the American Society for Microbiology 97: 165

Olson, D.; Moody, J. 1997: Cost effective utilization of the Testpack RSV enzyme immunoassay compared to DFA and viral culture. Abstracts of the General Meeting of the American Society for Microbiology 97: 191

Blick, K.E. 1996: Cost effective workstation consolidation using automated immunoassay systems. Clinical Chemistry 42(6 Part 2): S272

Gulati, S.C.; Bennett, C. 1996: Cost effectiveness analysis in growth factor use. Experimental Hematology 24(9): 1148

Udvarhelyi, I.S.; Colditz, G.; Rai, A.; Epstein, A.M. 1989: Cost effectiveness analysis is the methodology being used correctly?. Clinical Research 37(2): 327A

Chung, J.B.; Albert, D.A. 1998: Cost effectiveness analysis of Pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulfamethoxazole in patients with systemic lupus erythematosus or Wegeners granulomatosis on immunosuppressive therapy. Arthritis and Rheumatism 41(9 Suppl): S75

Etchason, J.; Calhoun, L.; Petz, L.D.; Snider, C.; Fink, A.; Kleinman, S. 1993: Cost effectiveness analysis of a predeposited autologous donation program. Blood 82(10 Suppl 1): 394A

Podrid, P.J.; Kowey, P.R.; Frishman, W.H.; Arnold, R.J.; Tuohy, D.J.; Beck, J.R. 1991: Cost effectiveness analysis of antiarrhythmic agents. Journal of the American College of Cardiology 17(2 Suppl A): 56A

Shaw, L.J.; Hachamovitch, R.; Marwick, T.H.; Heller, G.V.; Berman, D.S.; Borges Neto, S.; Travin, M.I.; Lauer, M.S.; Miller, D.D. 1997: Cost effectiveness analysis of stress myocardial perfusion imaging in stable angina patients Influence of age and pretest risk of coronary disease. Journal of the American College of Cardiology 29(2 Suppl A): 137A

Walshe, R.; Paulus, U.; Tesch, H.; Engert, A.; Diehl, V. 1998: Cost effectiveness analysis of the dose-intensified BEACOPP regimen for advanced stages of Hodgkins lymphoma. Annals of Hematology 77(Suppl 2): S192

Over, M.; Piot, P. 1992: Cost effectiveness analysis with externalities the case of std and aids prevention in developing countries. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : d454

Lue, Y.A. 1997: Cost effectiveness and quality of results using Uricult-R for the processing of voided urine specimens. Abstracts of the General Meeting of the American Society for Microbiology 97: 139

Roeller, S.K.; Scott, K.J.; Van Tassel, J.; Berchtold, L.; Pedersen, W.R.; Jorgensen, C.R.; Goldenberg, I.F. 1992: Cost effectiveness and safety of administering intravenous dobutamine on telemetry units to patients with severe congestive heart failure. Clinical Research 40(4): 858A

Chalfin, D.B.; Carlon, G.C. 1990: Cost effectiveness ce issues in the treatment of icu patients with gram negative sepsis gns. Critical Care Medicine 18(4 Suppl): S213

Alasmi, M.; Lou, F.Y.; Tsang, R.C. 1996: Cost effectiveness comparison of prevention strategies for neonatal group B streptococcal infection Application in a Metropolitan area. Pediatric Research 39(4 Part 2): 102A

Earnest, D.L.; Robinson, M.G. 1990: Cost effectiveness comparison of two treatments in patients with acute distal ulcerative colitis. Gastroenterology 98(5 Part 2): A3

Munshi, C.A.; Lauer, K.; Brown, B.; Borowski, C. 1994: Cost effectiveness for the 1990s A teaching hospitals experience. Anesthesiology 81(3A): A1206

Huckauf, H. 1996: Cost effectiveness in asthma therapy. Allergy 51(Suppl 32): 15

Thompson, R.S.; Taplin, S.H.; Carter, A.P.; Schnitzer, F. 1989: Cost effectiveness in program delivery. Cancer 64(12 Suppl): 2682-2689

Rubens, R.D. 1993: Cost effectiveness in the treatment of advanced solid tumours. European Journal of Cancer 29a (4): 604-605

Sutton, R.; Bourgeois, I. 1995: Cost effectiveness of AAI versus DDD pacing in sick sinus syndrome. European Heart Journal 16(ABSTR Suppl ): 103

Mond, H.G. 1993: Cost effectiveness of DDD and DDDR pacing. COMMITTEE OF THE ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING and ELECTROPHYSIOLOGY Author Symposium on Cardiac Pacing and Electrophysiology: Cardiac pacing and electrophysiology today: A new era of therapeutic arrhythmology 183-184

Ueda, K. 1993: Cost effectiveness of DDD pacemakers in geriatric patients with sick sinus syndrome. COMMITTEE OF THE ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING and ELECTROPHYSIOLOGY Author Symposium on Cardiac Pacing and Electrophysiology: Cardiac pacing and electrophysiology today: A new era of therapeutic arrhythmology 192-193

Mazumdar, S.; Dutta, S.; Abubaker, S. 1993: Cost effectiveness of DDD/DDR pacemakers. COMMITTEE OF THE ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING and ELECTROPHYSIOLOGY Author Symposium on Cardiac Pacing and Electrophysiology: Cardiac pacing and electrophysiology today: A new era of therapeutic arrhythmology 185-187

Huang, S.; Patel, H.; Bellman, G.C. 1997: Cost effectiveness of EHL versus the Candela pulse-dye laser in the management of the distal ureteral stone. Journal of Endourology 11(Suppl 1): S112

Schwartz, J.S.; Boccuzzi, S.J.; Glick, H.; Cook, J.R.; Kinosian, B.; Pedersen, T.R.; Kjekshus, J. 1997: Cost effectiveness of LDL-C reduction in diabetic CHD patients Implications from the Scandinavian Simvastatin Survival Study. Circulation 96(8): I504-I505, 10-21/97

Schwartz, J.S.; Boccuzzi, S.J.; Murray, J.F.; Roehm, J.B.; Cook, J.R.; Glick, H.; Kinosian, B.; Pedersen, T.; Kjekshus, J. 1997: Cost effectiveness of LDL-C reduction in medicare managed care CHD patients; implications from the Scandinavian simvastatin survival study. Journal of the American College of Cardiology 29(2 Suppl A): 226A

Waagstein, F.; Andersson, F. 1997: Cost effectiveness of Metoprolol in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology 29(2 Suppl A): 325A-326A

Mcclure, B.G. 1998: Cost effectiveness of Rhesus immunisation for neonatal practice. British Journal of Obstetrics and Gynaecology 105(Suppl 18): 26-27

Klein, A.L.; Grimm, R.A.; Black, I.W.; Orsinelli, D.A.; Manning, W.J.; Stoddard, M.F.; Piedmonte, M. 1994: Cost effectiveness of TEE-guided cardioversion with anticoagulation compared to conventional therapy in patients with atrial fibrillation. Journal of the American College of Cardiology 1994(SPEC ISSUE): 128A

Sutton, R.; Bourgeois, I. 1995: Cost effectiveness of VVI versus AAI/DDD pacing in sick sinus syndrome. European Heart Journal 16(ABSTR Suppl ): 512

Nienhuis S.J.; Ruissen C.J.; Hoogland H.J.; Gerver J.W.; Vles J.; De Haan J. 1991: Cost effectiveness of a doppler policy in suspected intrauterine growth retardation a randomized controlled trial. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 32

Kindscher, J.; Kovac, A.; Crist, D.; Johnson, G. 1998: Cost effectiveness of a drug tray stocking system. Anesthesiology 89(3A): A1345

Gaspoz, J.M.; Lee, T.H.; Weinstein, M.C.; Cook, E.F.; Weisberg, M.C.; Goldman, L. 1991: Cost effectiveness of a new short stay unit to rule out acute myocardial infarction. Clinical Research 39(2): 222A

Heeschen, C.; Hamm, C.W.; Goldmann, B.U.; Wohlrath, S.; Van Hout, B.A.; Simoons, M.L. 1998: Cost effectiveness of abciximab in patients with unstable angina according to the troponin T status. Circulation 98(17): I358-I359

Tobin, M.G.; Pinski, S.L.; Tchou, P.J.; Ching, E.A.; Trohman, R.G. 1997: Cost effectiveness of administration of intravenous anesthetics for direct-current cardioversion by nonanesthesiologists. American Journal of Cardiology 79(5): 686-688

Lems, W.F.; De Fraiture, D.M.I.; Van Leeuwen, E.; Bijlsma, J.W.J. 1995: Cost effectiveness of alfacalcidol in postmenopausal women. Calcified Tissue International 56(5): 489

Javitt, J.C.; Canner, J.K.; Sommer, A. 1989: Cost effectiveness of alternative approaches to the detection and treatment of diabetic retinopathy. IOVS Investigative Ophthalmology and Visual Science 30(3): 5

Le, C.T.; Winter, T.D.; Boyd, K.J.; Ackerson, L. 1997: Cost effectiveness of an HIV-dedicated interdisciplinary team in managed care. Journal of Investigative Medicine 45(1): 124A

Hindi Alexander, M.; Throm, J.; Zielezny, M.; Middleton, E.Jr 1989: Cost effectiveness of an asthma education program. Journal of Allergy and Clinical Immunology 83(1): 248

Macartney, K.M.; Gorelick, M.H.; Hodinka, R.L.; Martinez, M.L.; Bell, L.M. 1998: Cost effectiveness of an infection control program to reduce nosocomial respiratory syncytial virus infection. Pediatric Research 43(4 Part 2): 151A

Cairns, J.A. 1998: Cost effectiveness of antenatal prophylaxis. British Journal of Obstetrics and Gynaecology 105(Suppl 18): 27

Albers, B.A.; Patka, P.; Haarman, H.J.T.M.; Kostense, P.J. 1994: Cost effectiveness of antibiotic prophylaxis for closed fractures. Unfallchirurg 97(12): 625-628

Holzer, S.S.; Gable, C.B.; Muggeo, L.; Schroeder, D.; Baum, K.; Friedman, R.B. 1991: Cost effectiveness of antibiotics in the treatment of pediatric and adult pneumonias according to severity of illness. Pharmaceutical Research (New York) 8(10 Suppl): S70

Hafner, J.M.; Buddemeier, K.; Rosenson, R.S. 1992: Cost effectiveness of assessing Lp in the management of dyslipidemic subjects. Circulation 86(4 Suppl 1): I703

Nnodu, O.E.; Njoku, O.S.; Odunubi, O.; Akiode, T. 1998: Cost effectiveness of autologous blood transfusion for orthopaedic and general surgical patients in Nigeria. British Journal of Haematology 102(1): 215

Dundjerski Kanju, V.; Obradovic, B.; Kostic, D.; Nedeljkov, Z.; Mihajlovic, B. 1996: Cost effectiveness of bacteriological control of the cardiosurgical operating theatre. Israel Journal of Medical Sciences 32(10): 1020

Andrasik, F.; Packard, R.C. 1989: Cost effectiveness of biofeedback therapy for headache a review. Headache 29(5): 319

Roberts, W.A.; Newby, M.; Kirkley, S. 1995: Cost effectiveness of blood donated by intraoperative hemodilution compared to autologous predeposit. Transfusion 35(10 Suppl): 73S

Schmitz, K.L.; Burge, M.R.; Schade, D.S. 1995: Cost effectiveness of blood glucose averaging for assessment of glycemic control in IDDM. Journal of Investigative Medicine 43(Suppl 1): 164A

Koistinen, J. 1996: Cost effectiveness of blood transfusion. Vox Sanguinis 70(Suppl 3): 86-88

Welch, H.G.; Larson, E.B. 1989: Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. New England Journal of Medicine 321(12): 807-812

Matchar, D.B.; Pauk, J.; Lipscomb, J. 1994: Cost effectiveness of carotid endarterectomy A decision model analysis of three clinical scenarios. Stroke 25(1): 249

Glick, H.; Kinosian, B. 1995: Cost effectiveness of cholesterol modification A model based on the coronary primary prevention trial. Jgim 10(4 Suppl): 43

Pym, B.; Sandstad, J.; Seville, P.; Byth, K.; Piper, D.W. 1989: Cost effectiveness of cimetidine treatment of chronic peptide ulcer a case control study. Australian and New Zealand Journal of Medicine 19(5 Suppl 1): 596

O'donnell, M.; Adair, T.; Chadda, R.; Chadda, K.D. 1995: Cost effectiveness of combined comprehensive electrophysiology testing and head-up tilt table testing in the management syncope of unknown origin. Journal of Investigative Medicine 43(Suppl 3): 494A

Mchutchison, J.G.; Woolley, J.M.; Nyberg, L.M. 1997: Cost effectiveness of consensus interferon therapy for chronic HCV infection. Hepatology 26(4 Part 2): 421A

Dei Cas, R.; Javitt, J.; Chiang Y P.; Canner, J. 1991: Cost effectiveness of cryotherapy for retinopathy of prematurity. IOVS Investigative Ophthalmology and Visual Science 32(4): 1146

Javitt, J.C.; Canner, J.K.; Sommer, A. 1989: Cost effectiveness of current approaches to the control of retinopathy in type i diabetics. Ophthalmology 96(2): 255-264

Rowan, A.J.; French, J.A.; Luciano, D.; Rosenbaum, D.H. 1989: Cost effectiveness of daytime outpatient eeg video monitoring. Neurology 39(3 Suppl 1): 212

Chen, X.; Yao, Q.; Eisenberg, J.M.; Glick, H.; Norman, S.A. 1991: Cost effectiveness of diabetes education and home glucose monitoring in uncontrolled noninsulin dependent diabetics in shanghai. Clinical Research 39(2): 459A

Pineo, G.F.; Hull, R.D.; Feldstein, W.; Raskob, G.E.; Valentine, K.A. 1996: Cost effectiveness of diagnosis and management of deep vein thrombosis in symptomatic patients comparing low-molecular-weight heparin and intravenous heparin for treatment. Clinical and Investigative Medicine 19(4 Suppl): S31

Hull, R.D.; Feldstein, W.; Valentine, K.A.; Stein, P.D.; Pineo, G.F. 1996: Cost effectiveness of diagnosis and management of pulmonary embolism using low-molecular-weight heparin or intravenous heparin for treatment. Clinical and Investigative Medicine 19(4 Suppl): S31

Hull, R.D.; Feldstein, W.; Pineo, G.F.; Raskob, G.E. 1995: Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients. Thrombosis and Haemostasis 74(1): 189-196

Cammelli, L.; Lucchelli, M.; Silvestris, M.; Motta, F.; Zoppei, G. 1993: Cost effectiveness of different AIDS care patterns. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 923

Jung, P.; Glick, H.; Kinosian, B.; Schulman, K.; Jacobson, T.; Eisenberg, J. 1991: Cost effectiveness of drug treatment for high blood cholesterol. Clinical Research 39(2): 412A

Smith, Y.A.; Hoy, D.A.; Owens, M.R.; Layne, L.C. 1992: Cost effectiveness of early hospital discharge ehd of premature infants pi with safe short term home monitoring hm. Pediatric Research 31(4 Part 2): 261A

Hilleman, D.E.; Mohiuddin, S.M.; Destache, C.J.; Stoysich, A.M.; Larsen, K.E.; Sketch, M.H. 1990: Cost effectiveness of early versus late initiation of warfarin during heparin therapy. Pharmacotherapy 10(3): 246

Bansal, R.; Carpenter, S.L.; Tierney, W.M.; Nostrant, T.T.; Elta, G.H.; Thompson, N.; Scheiman, J.M. 1996: Cost effectiveness of endoscopic ultrasound for pre-operative localization of pancreatic endocrine tumors A case-control study. Gastroenterology 110(4 Suppl): A3

Chuck, A.; Ohinmaa, A.; Tilley, P.; Singh, A.; Jacobs, P. 2008: Cost effectiveness of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis. International Journal of Std and Aids 19(6): 393-399

Ecker, M.; Snead, O.C.rter, IIi 1994: Cost effectiveness of epilepsy surgery in children Preliminary data. Epilepsia 35(Suppl 8): 49

Heidenreich, P.A.; Bear, J.; Foster, E. 1994: Cost effectiveness of evaluating suspected mitral valve prolapse with echocardiography. Circulation 90(4 Part 2): I43

Leung, D.Y.; Dawson, I.G.; Haluska, B.; Marwick, T.H. 1996: Cost effectiveness of exercise echocardiography as the initial test for diagnosis of coronary heart disease in patients with mitral valve prolapse. European Heart Journal 17(ABSTR Suppl ): 250

Patterson, R.E.; Eisner, R.L.; Horowitz, S.F. 1991: Cost effectiveness of four clinical strategies to diagnose coronary disease superiority of pet vs thallium 201 exercise ecg and coronary angiography at various prevalences. Circulation 84(4 Suppl 2): II48

Pan, W.; Teruya, J.; Abe, K.; Yuasa, S. 1996: Cost effectiveness of frozen autologous blood in elective surgery. Transfusion 36(9 Suppl): 10S

Cheung, T.W.; Fahs, M.; Sacks, H.S. 1992: Cost effectiveness of ganciclovir dhpg versus foscarnet fos for cytomegalovirus cmv retinitis in patients with aids. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : d517

Held, P.J.; Wolfe, R.A.; Ashby, V.B.; Orzol, S.M.; Port, F.K.; Golper, T. 1997: Cost effectiveness of hemodialysis compared to peritoneal dialysis in the first year of dialysis. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 219A

Stern, M.F.; Dittus, R.S.; Birkhead, G.; Huber, R.; Scwartz, J.; Morse, D. 1992: Cost effectiveness of hepatitis b immunization strategies for high risk people. Clinical Research 40(2): 568A

Schulman, K.A.; Kinosian, B.P.; Jacobson, T.A.; Glick, H.; Willian, M.K.; Koffer, H.; Eisenberg, J.M. 1990: Cost effectiveness of high blood cholesterol reduction methodology and results. Clinical Research 38(2): 321A

Ralley, F.E.; Devarennes, B.; Robitaille, M. 1996: Cost effectiveness of high vs low dose tranexamic acid on blood loss and blood product requirements after cardiac surgery. Canadian Journal of Anaesthesia 43(5 Part 2): A35

Rahman, S.; Howard, P. 1994: Cost effectiveness of home oxygen therapy. Kira, S, Petty, T L International Congress Series; Progress in domiciliary respiratory care: Current status and perspective 149-157

Olson, G.; Nagey, D.; Berendes, H. 1993: Cost effectiveness of home uterine activity monitoring. American Journal of Obstetrics and Gynecology 168(1 Part 2): 374

Share, L.; Roworth, S.; Jacobs, M.; Kiwi, R.; Fanaroff, A.A. 1998: Cost effectiveness of implementation of guidelines for preventing early onset group B streptococcal infection at MacDonald Women Hospital. Pediatrics 102(3 Part 2): 772

Agertoft, L.; Pedersen, S. 1997: Cost effectiveness of inhaled budesonide in children with chronic asthma. European Respiratory Journal Suppl 10(25): 81S

O'dell, S.L.; Kinasewitz, G.T.; Petrone, R.L. 1994: Cost effectiveness of intensive care for patients with malignancy. Chest 106(2 Suppl): 72S

Pasha, T.M.; Douglas, D.D.; Krom, R.A.; Wiesner, R.H. 1998: Cost effectiveness of lamivudine and hepatitis B immunoglobulin after liver transplantation for hepatitis B. Hepatology 28(4 Part 2): 348A

Brand, A. 1994: Cost effectiveness of leukocyte depletion. Current Studies in Hematology and Blood Transfusion 60: 134-143

Egan, T.F.; Henry, D.H. 1998: Cost effectiveness of liposomal Daunorubicin versus liposomal doxorubicin in Kaposi Sarcoma. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 17(4): A17

Schulman, K.A.; Lynn, L.A.; Eisenberg, J.M. 1990: Cost effectiveness of low dose zidovudine therapy for asymptomatic patients infected with human immunodeficiency virus. Clinical Research 38(2): 472A

Whitlock, W.L.; Ketchum, D.M.; Fitzpatrick, T.M. 1991: Cost effectiveness of metered dose inhalers over nebulizers. American Review of Respiratory Disease 143(4 Part 2): A454

Aiello, L.P.; Javitt, J.C.; Canner, J.K. 1990: Cost effectiveness of multicenter trials savings produced by the diabetic retinopathy study. IOVS Investigative Ophthalmology and Visual Science 31(4): 343

Solomon, N.A.; Garber, A.M. 1996: Cost effectiveness of noninvasive tests for patients with intermediate probability of coronary artery disease. Jgim 11(Suppl 1): 61

Rodger, M.; Bredeson, C.; Wells, P.; Beck, J.; Kearns, B.; Huebsch, L. 1997: Cost effectiveness of outpatient LMWH compared to inpatient standard heparin in deep vein thrombosis treatment. Clinical and Investigative Medicine 20(4 Suppl): S32

Kovacs, M.J.; Dhawan, R.; Kemp, K.; Morrow, B.; Smith, V.; Kovacs, J. 1997: Cost effectiveness of outpatient management of DVT or PE with dalteparin as compared to in-hospital with standard heparin. Blood 90(10 Suppl 1 Pt 1): 296A

Martin, E.; Bennett, A.H. 1992: Cost effectiveness of outpatient vs inpatient penile prosthesis surgery. Journal of Urology 147(4 Suppl): 310A

Howard, P. 1989: Cost effectiveness of oxygen therapy. European Respiratory Journal. Suppl 7: 637s-639s

Weintraub, W.S.; Tailey, J.D. 1989: Cost effectiveness of percutaneous transluminal coronary angioplasty in the treatment of patients with single vessel coronary disease and severe stable angina. Clinical Research 37(2): 327A

Tosteson, A.N.A.; Weinstein, M.C.; Williams, L.; Goldman, L. 1991: Cost effectiveness of population approaches to reduce serum cholesterol levels. Clinical Research 39(2): 298A

Duong, T.H.; Fonarow, G.; Laks, H.; Hendi, P.; Czernin, J.; Phelps, M.; Schelbert, H.; Maddahi, J. 1996: Cost effectiveness of positron emission tomography in the management of ischemic cardiomyopathy patients who are referred for cardiac transplantation. Journal of the American College of Cardiology 27(2 Suppl A): 144A

Ferson, M.J.; Robertson, P.W.; Whybin, L.R. 1994: Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps. Medical Journal of Australia 160(8): 478-482

Holme, S.; Creed, F.; Mbaya, P.; Lancashire, S.; Tomenson, B.; Williams, B. 1997: Cost effectiveness of psychiatric day and in-patient care. European Psychiatry 12(Suppl 2): 167S

Slagel, D.D.; Hughes, J.H.; Silverman, J.F.; Thomas, P.A.; Raab, S.S. 1996: Cost effectiveness of pulmonary fine needle aspiration and immunocytochemistry in the work-up of patients with a lung malignancy and a history of cancer. Modern Pathology 9(1): 38A

Emberton, M.; Hrouda, D. 1998: Cost effectiveness of radical prostatectomy of over conservative management for localised prostate cancer. Journal of Urology 159(5 Suppl): 301

Silverstein, B.; Venzon, M. 1991: Cost effectiveness of rehabilitation levels of care for medicaid patients. Archives of Physical Medicine and Rehabilitation 72(10): 790

Robinson, A.; Epp, E.; Tetreault, J. 1992: Cost effectiveness of repeat testing to verify reactive hepatitis marker results in an enzyme immunoassay eia system. Abstracts of the General Meeting of the American Society for Microbiology 92: 485

Mchutchison, J.G.; Woolley, J.M.; Nyberg, L.M. 1997: Cost effectiveness of retreatment with consensus interferon for chronic hepatitis C. Hepatology 26(4 Part 2): 421A

Guzman, G.; Phatak, P.D.; Woll, J.; Phelps, C.E. 1991: Cost effectiveness of screening for hemochromatosis. Clinical Research 39(2): 348A

Hillson, S.D.; Rich, E.C.; Stoeckeler, J.; Tuchman, M.; Woods, W.G.; Connelly, D.P. 1989: Cost effectiveness of screening for neuroblastoma impact of pseudocancer. Clinical Research 37(2): 313A

Simon, J.; Gray, A.; Clarke, P.; Wade, A.; Neil, A.; Farmer, A.; French, D.; Holman, R.; Kinmonth, A.-L.; Mant, D.; Ziebland, S.; Yudkin, P.; Stott, N.; Sutton, S.; Tewson, H.; Chapman, D.; Hearnshaw, H.; Goyder, E.; Glasziou, P.; Jiwa, M.; Gordon, M.; French, D.; Kinmonth, A.-L.; Selwood, M.P.; Craven, A.; Yudkin, P.; Fuller, A.; Walker, V.; Baigent, C.; Levy, J.; Wheatley, K.; Kirlow, H.; Chapman, M.; Turner, S.; Casbolt, A.; Dobson, K.; Willert, A.; Roberts, A.; Wood, H.; Islam, K. 2008: Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Bmj 336(7654): 1177-1180

Gordon, M.; Haddix, A.; Steketee, R.W.; Nieburg, P.L.; Shaffer, N.; Wiktor, S.; Hu, D.; Simonds, R.J.; Rogers, M. 1996: Cost effectiveness of short-course zidovudine to prevent perinatal HIV in developing country settings. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol Two One world: One hope : 237

Lopez Plaza, I.; Weissfeld, J.; Triulzi, D.J. 1996: Cost effectiveness of single donor versus pooled platelets for avoiding donor exposures in primary coronary artery bypass grafting. Transfusion 36(9 Suppl): 47S

Triulzi, D.J.; Anderegg, K.A.; Weissfeld, J.; Kiss, J.E.; Rybka, W.B. 1995: Cost effectiveness of single donor vs random donor platelets for avoiding donor exposures in bone marrow transplant recipients. Blood 86(10 Suppl 1): 109A

Shennan, A.; Dunn, M.; Possmayer, F. 1989: Cost effectiveness of single dose surfactant prophylaxis in infants of less than 30 weeks gestation. Pediatric Research 25(4 Part 2): 231A

Chouaid, C.; Roux, P.; Poirot, J.L.; Lavrard, I.; Housset, B. 1993: Cost effectiveness of the PCR technique used in induced sputum for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected subjects. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 380

Tosteson, A.N.A.; Goldman, L.; Udvarhelyi, I.S.; Lee, T.H. 1991: Cost effectiveness of the ccu for emergency room patients with acute chest pain. Clinical Research 39(2): 161A

Callaghan, E.J.; Grzybicki, D.M.; Raab, S.S. 1998: Cost effectiveness of the histologic examination of intervertebral disc specimens. Laboratory Investigation 78(1): 182A

Netser, J.C.; Robinson, R.A.; Raab, S.S. 1996: Cost effectiveness of the histologic examination of tonsils and adenoids. Modern Pathology 9(1): 103A

Joo, J.S.; Gilliland, R.; Wexner, S.D. 1997: Cost effectiveness of the management of constipation. Gastroenterology 112(4 Suppl): A756

Holzer, S.S.; Gable, C.B.; Friedman, R. 1991: Cost effectiveness of the pneumococcal vaccine implications for managed care. Pharmaceutical Research (New York) 8(10 Suppl): S71

Pepper, P.V.; Owens, D.K. 1998: Cost effectiveness of the pneumococcal vaccine in the Navy and Marine Corps. JGIM 13(Suppl 1): 32

Huse, D.M.; Lacey, M.J.; Oster, G.; Epstein, A.M. 1990: Cost effectiveness of ticlopidine in primary stroke prevention. Clinical Research 38(2): 257A

Mark, D.B.; Naylor, C.D.; Nelson, C.L.; Jollis, J.G.; Clapp Channing, N.; Hlatky, M.A. 1993: Cost effectiveness of tissue plasminogen activator relative to streptokinase in acute myocardial infarction Results from the GUSTO trial. Circulation 88(4 Part 2): I144

Gable, C.B.; Baum, K.; Holzer, S.S.; Muggeo, L.; Schroeder, D.; Friedman, R.B. 1991: Cost effectiveness of transdermal versus oral nitrates in the treatment of angina according to severity of illness. Pharmaceutical Research (New York) 8(10 Suppl): S70

Rhodes, M.; Sacco, W.; Smith, S.; Boorse, D. 1990: Cost effectiveness of trauma quality assurance audit filters. Journal of Trauma 30(6): 724-727

Heeschen, C.; Hamm, C.W.; Goldmann, B.U.; Vahanian, A.; Adgey, J.; Macaya, C.; Simoons, M. 1998: Cost effectiveness of treatment with abciximab in patients with unstable angina according to the troponin status Results from the CAPTURE trial. European Heart Journal 19(ABST Suppl ): 402

Gordon, G.S.; Fisher, C.F.; Slotman, G.J.; Opal, S.M.; Pribble, J.P.; Stiles, D.M.; Catalano, M.A. 1992: Cost effectiveness of treatment with interleukin 1 receptor antagonist il 1ra in patients with sepsis syndrome. Clinical Research 40(2): 254A

Reginster, J.Y. 1996: Cost effectiveness of treatments in osteoporosis. Journal of Rheumatology 23(7): 1312-1313

Crossley, G.H.; Plumb, V.J.; Dailey, S.M.; Kay, G.N. 1990: Cost effectiveness of type ic antiarrhythmic agents for ventricular tachycardia related to coronary artery disease. Circulation 82(4 Suppl 3): III434

Barnas, G.P.; Mckinney, W.P.; Young, M.J. 1989: Cost effectiveness of using hemoquant to confirm positive fecal occult blood tests. Clinical Research 37(4): 979A

Shah, B.D.; Gambhir, S.S.; Shepherd, J.; Hoh, C.H.; Allen, M.; Phelps, M.E. 1997: Cost effectiveness of whole-body FDG PET in the staging and management of non-small cell lung carcinoma. Journal of Nuclear Medicine 38(5 Suppl): 245P

Lebrun, T.; Sailly, J.C.; Decroly, F.; Dumas, Y.; Beaumont, D. 1990: Cost effectiveness study of a new anti epileptic drug vigabatrin for treatment of refractory epilepsy. Dphm/Inserm (Directeur De La Pharmacie Et Du Medicament/Institut National De La Sante Et De La Recherche Medicale) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 213 L'europe Du Medicament: Realites Et Ambitions; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 213 Europe And Drugs: Realities And Ambitions); Fourth Colloquium Of The Dphm-Inserm (Director Of Pharmacy And Drugs And National Institute Of Health And Medical Rese

Fagnani, F.; Landman, R.; Lafuma, A. 1990: Cost effectiveness study of erythropoietin in treatment of anemia in dialysis patients. Dphm/Inserm (Directeur De La Pharmacie Et Du Medicament/Institut National De La Sante Et De La Recherche Medicale) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 213 L'europe Du Medicament: Realites Et Ambitions; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 213 Europe And Drugs: Realities And Ambitions); Fourth Colloquium Of The Dphm-Inserm (Director Of Pharmacy And Drugs And National Institute Of Health And Medical Rese

Laudat, P.; Dupont Franklin, Y.; Audurier, A.; Mayeux, D.; Kohler, F. 1992: Cost effectiveness study of urinary screening using a dipstick test with an automated optical reading system. Semaine des Hopitaux 68(9): 233- 239

Eley, J.W. 1991: Cost effectiveness what does it mean and how should it be used?. Southern Medical Journal 84(9): 2S94

Verma, R.P.; Worrell, L.; Torcato, B.; Cossey, M.; Ross, R.D. 1994: Cost effects of antenatal steroid therapy in very low birth weight infants. Pediatric Research 37(4 Part 2): 275A

Vohra, K.; Smith, M.; Marsden, A.; Pass, K.A. 1998: Cost efficacy of a new filter paper in New York State Newborn Screening Program. Pediatric Research 43(4 Part 2): 233A

Korenblat, P.; Farrar, J. 1996: Cost efficacy of nedocromil sodium aerosol for asthma. Journal of Allergy and Clinical Immunology 97(1 Part 3): 253

Payne, G.E.; Wyatt, K.L.; Keaveney, B.; Garratt, C.J.; Skehan, J.D. 1994: Cost efficiency in pacemaker follow-up. European Heart Journal 15(ABSTR Suppl ): 75

Assaf,A.; Matawie,K.M. 2008: Cost efficiency modeling in health care foodservice operations. International Journal Of Hospitality Management: 4, 604-613

Kluge,R. 2008: Cost efficient fertilizers Compost use in crops provides basic nutrients. Neue Landwirtschaft: , 51-54

Kereiakes, D.J.; Mcdonald, M.B.; Abbottsmith, C.W.; Broderick, T.M.; Roth, E.M.; Whang, D.D.; Hattemer, C.R.; Runyon, J.P.; Schneider, J.F. 1998: Cost efficient stenting A multi-faceted approach. Journal of the American College of Cardiology 31(2 Suppl A): 492A

Perez, M.K.; Johansen, P.A.; Dowd, L.A.; Vondrasek, J.R.; Rothstein, J.D.; Robinson, M.B. 1996: Cost endogenously express the GLAST subtype of Na+-dependent glutamate transporter. Society for Neuroscience Abstracts 22(1-3): 1572

Madrigal, G. 1994: Cost estimate of kidney transplants in Costa Rica: comparison to chronic dialysis. Transplantation Proceedings 26(1): 121

Sultsmann, M.K.; Kallassalu, H. 1998: Cost estimation in Estonian blood transfusion system. Vox Sanguinis 74(Suppl 1): 1651

Chan, A.L.F.; Lee, H.Y.; Ho, C.-H.; Cham, T.-M.; Lin, S.J. 2008: Cost evaluation of adverse drug reactions in hospitalized patients in Taiwan: a prospective, descriptive, observational study. Current Therapeutic Research 69(2): 118-129

Foster, D.M.; Wheeler, M.D.; Griffin, G.D. 1997: Cost evaluation of new employee training in a cGMP environment. Transfusion 37(9 Suppl): 130S

Gerweck,G. 2008: Cost explosion in German health system - critical comments of a veterinarian. Tierarztliche Umschau: 7, 395-399

Schneider, K.; Zernicke, R.F.; Thelen, E. 1994: Cost function analysis of infant reaching. Journal of Biomechanics 27(6): 740

Pajeau, M.E.; Waters, A.T.; Bennett, C.L. 1997: Cost identification analysis of prostate cancer screening in a rural hospital network. Journal of Urology 157(4 Suppl): 118

Lu, Z.J.; Luo, R.; Erder, H.; Heil, G.; Ganser, A.; Lechner, K.; Yin, J.L.; Szer, J.; Barge, A. 1996: Cost impact of filgrastim as an adjunct to chemotherapy for patients with acute myeloid leukemia. Blood 88(10 Suppl 1 Part 1-2): 209A

Blanco, J.; Weintraub, W.S.; Shen, Y.; Chronos, H.; Mcadams, D.; Chronos, N.; Ghazzal, Z.M.B.; King, S.B.IIi 1998: Cost impact of high pressure inflations and therapy with aspirin and ticlopidine after coronary stenting. Journal of the American College of Cardiology 31(2 Suppl A): 17A

Klim, J.B.; Brown, J.; Syrett, N.; Cohn, J. 1996: Cost impact of reducing exacerbations of asthma in multi-national clinical trials with zafirlukast. European Respiratory Journal Suppl 9(23): 52S

Aina,B.A.; Tayo,F.; Taylor,O. 2008: Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals. Journal Of Infection In Developing Countries: 1, 68-72

Pepine, C.J.; Mark, D.; Bourassa, M.; Chaitman, B.; Knatterud, G.; Forman, S.; Pratt, C.; Sopko, G.; Conti, C.R.chard 1996: Cost implications for treatment of cardiac ischemia An ancillary asymptomatic cardiac ischemia pilot study. Journal of the American College of Cardiology 27(2 Suppl A): 186A

Allgoewer, M. 1990: Cost implications of accidents and the type of fracture care. Border, J R (Ed ) Blunt Multiple Trauma: Comprehensive Pathophysiology And Care Xxi+861p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus Maps 775-782

Covinsky, K.E.; Quinn, L.M.; Siddique, R.M.; Palmer, R.M.; Kresevic, D.M.; Kowal, J.; Landefeld, C.S. 1995: Cost implications of an inpatient medical unit for acute care of elders Better outcomes need not cost more. Jgim 10(4 Suppl): 54

Ohman, E.M.; Talley, J.D.; George, B.S.; Kern, M.J.; White, C.J.; Lundergan, C.; Gurbel, P.A.; Berdan, L.G.; Califf, R.M.; Mark, D.B. 1995: Cost implications of aortic counterpulsation in acute myocardial infarction Results from a randomized clinical trial. European Heart Journal 16(ABSTR Suppl ): 102

Anderson, M.H.; Paul, V.; Farrell, T.; Camm, A.J. 1991: Cost implications of controlled trials of the implantable cardioverter defibrillator. European Heart Journal 12(ABSTR Suppl): 316

Shugars, D.; Bader, J. 1992: Cost implications of differences in dentists treatment recommendations. Journal of Dental Research 71(Special Issue): 641

Lawson, C.S.; Chase, R.; Morgan, J.M.; Dawkins, K.D. 1995: Cost implications of implementing the British pacing and electrophysiology group pacing guidelines A five-year study of 1690 implants. European Heart Journal 16(ABSTR Suppl ): 143

Bayliff, C.D.; Bierbrier, G.S. 1993: Cost implications of ketorolac therapy. Canadian Journal of Hospital Pharmacy 46(2): 85-87

Rubin, D.N.; Ballal, R.S.; Marwick, T.H. 1996: Cost implications of pre-operative stress imaging before noncardiac surgery Importance of assessing operative risk and patient risk. Circulation 94(8): I566

Pourriat, J.L. 1998: Cost implications of the practice of anaesthesiology. European Journal of Anaesthesiology 15(1): 124

Sinclair, J.C. 1993: Cost in maternal side effects to prolong pregnancy or reduce low birthweight using ritodrine. Pediatric Research 33(4 Part 2): 275A

Moore, R. 1996: Cost issues in the use of Neoral. Johnson, R Round Table Series Royal Society of Medicine Press; Rational use of Neoral 44-48

Agha, Z.; Weinstein, R.S.; Dunn, B.E. 1998: Cost minimization analysis of a telemedicine service. JGIM 13(Suppl 1): 32

Gobbi, M.; Pieri, I.; Clavio, M.; Quinton, S.; Masoudi, B.; Gatto, S.; Cerri, R.; Pietrasanta, D.; Ballerini, F.; Caveliere, M.; Miglino, M.; Beltrami, G.; Canepa, L.; Damasio, E. 1998: Cost of De Novo acute myeloid leukemia induction therapy in adults Comparison between EORTC-GIMEMA AML10 and flang regimens. Blood 92(10 Suppl 1 Part 1-2): 210B-211B

Agrawal, K.P. 1997: Cost of ET kids. Indian Journal of Animal Sciences 67(2): 134-135

Eggleston, A.; Wigerinck, A.; Haycox, A. 1997: Cost of GORD-medication in clinical practice in patients with a first diagnosis of GORD based on prescription-data analysis. Gastroenterology 112(4 Suppl): A13

Fleerackers, Yon; De Cock, R.; De Graeve, D.; Van Renterghem, H.; Doukrou, T.; Colebunders, R. 1996: Cost of HIV infection for the Belgian patient. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol Two One world: One hope : 400

Levin, T.R.; Schmittdiel, J.A.; Kunz, K.; Henning, J.M.; Henke, C.J.; Colby, C.J.; Selby, J.V. 1997: Cost of acid-related disorders to a large health maintenance organization. Gastroenterology 112(4 Suppl): A26

Shumaker, D.A.; Cobanoglu, A.M.; Silberbach, M. 1992: Cost of admission to repair congenital heart disease chd can be predicted. Journal of the American College of Cardiology 19(3 Suppl A): 395A

Ray, N.; Rinehart, C.; Thamer, M.; Kaliner, M.; Josephs, S.; Pung, Y.H.; Gergen, P.; Baraniuk, J.N. 1998: Cost of allergic rhinoconjunctivitis Estimation by the Delphi method. Journal of Allergy and Clinical Immunology 101(1 Part 2): S44

Rose, K.; Barr, A.; Cohen, M. 1998: Cost of anesthetic care What drives the dollars. Anesthesiology 89(3A): A1182

Rose, K.; Cohen, M.; Porter, J.; O'brien Pallas, L.; Wall, R. 1997: Cost of anesthetic practice patterns and outcome Does more equal less?. Anesthesiology 87(3 Suppl): A1012

Votte P.; Bou P.; Schmit J.L.; Eb F. 1992: Cost of antibiotic therapy and bacterial ecology an attempt of correlation. Journal de Pharmacie Clinique 11(2): 134-139

Buck, R.O.; Wheeler, R.R.; Zeitz, H.J.; Lane, I.P.A. 1998: Cost of asthma care in an IPA setting. Journal of Allergy and Clinical Immunology 101(1 Part 2): S178

Minser, R.E.; Levy, H.; Robinson, J.K. 1994: Cost of attempted suicide by overdose and correlation with the level of intent to die. Clinical Research 42(1): 63A

Sutcliffe, N.; Clarke, A.; Levinton, C.; Isenberg, D.A. 1997: Cost of care and predictors of cost in systemic lupus erythematosus. Arthritis and Rheumatism 40(9 Suppl): S171

Graham, K.B.; Berger, J.W.; Patalano, V.J.; Kunzweiler, T.P. 1996: Cost of care and severity of conditions in patients presenting to a large, urban ophthalmic emergency department. IOVS Investigative Ophthalmology and Visual Science 37(3): S1

Yabroff, K.R.; Lamont, E.B.; Mariotto, A.; Warren, J.L.; Topor, M.; Meekins, A.; Brown, M.L. 2008: Cost of care for elderly cancer patients in the United States. Journal of the National Cancer Institute 100(9): 630-641

Kotagal, U.R.; Hickey, F.; Steichen, J.; Atherton, H.; Gratton, T.; Perlstein, P. 1994: Cost of care for infants less than or equal to 800 GMS Appropriate allocation of health resources?. Pediatric Research 35(4 Part 2): 276A

Silverstein, M.D.; LoftusE.V.Jr.; Sandborn, W.J.; Tremaine, W.J.; Harmsen, W.S.; Zinsmeister, A.R. 1997: Cost of care of Crohns disease in the community setting. Gastroenterology 112(4 Suppl): A1093

Pomerance, J.J.; Pomerance, L.J.; Gottlieb, J.A. 1993: Cost of caring for infants weighing 500-749 g at birth in 50 gram increments. Pediatric Research 33(4 Part 2): 231A

Calhoun, E.A.; Fishman, D.A.; Roland, P.Y.; Lurain, J.R.; Naseer, F.A.; Bennett, C.L. 1998: Cost of chemotherapy-induced hematologic and neurologic toxicity. Blood 92(10 Suppl 1 Part 1-2): 130B

Weintraub, W.S. 1998: Cost of clinical restenosis and cost-effectiveness of therapy to prevent it. Journal of the American College of Cardiology 31(2 Suppl A): 50A